DEF 14A
1
l91488adef14a.txt
THE SHERWIN WILLIAMS COMPANY--DEFINITIVE PROXY
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
SCHEDULE 14A
(RULE 14a)
INFORMATION REQUIRED IN PROXY STATEMENT
SCHEDULE 14A INFORMATION
PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES
EXCHANGE ACT OF 1934
(AMENDMENT NO. )
Filed by the Registrant [X]
Filed by a Party other than the Registrant [ ]
Check the appropriate box:
[ ] Preliminary Proxy Statement [ ] CONFIDENTIAL, FOR USE OF THE COMMISSION
ONLY (AS PERMITTED BY RULE 14a-6(e)(2))
[X] Definitive Proxy Statement
[ ] Definitive Additional Materials
[ ] Soliciting Material Pursuant to sec.240.14a-11(c) or sec.240.14a-12
THE SHERWIN-WILLIAMS COMPANY
(NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
THE SHERWIN-WILLIAMS COMPANY
101 PROSPECT AVENUE, N.W.
CLEVELAND, OHIO 44115
(216) 566-2000
(NAME OF PERSON(S) FILING PROXY STATEMENT)
Payment of Filing Fee (Check the appropriate box):
[X] No fee required.
[ ] Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.
(1) Title of each class of securities to which transaction applies:
(2) Aggregate number of securities to which transaction applies:
(3) Per unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the
filing fee is calculated and state how it was determined):
(4) Proposed maximum aggregate value of transaction:
(5) Total fee paid:
[ ] Fee paid previously with preliminary materials.
[ ] Check box if any part of the fee is offset as provided by Exchange Act Rule
0-11(a)(2) and identify the filing for which the offsetting fee was paid
previously. Identify the previous filing by registration statement number,
or the Form or Schedule and the date of its filing.
(1) Amount Previously Paid:
(2) Form, Schedule or Registration Statement No.:
(3) Filing Party:
(4) Date Filed:
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
[SHERWIN WILLIAMS LOGO]
THE SHERWIN-WILLIAMS COMPANY
------------------
NOTICE OF ANNUAL MEETING OF SHAREHOLDERS
To Be Held April 24, 2002
------------------
The Annual Meeting of Shareholders of THE SHERWIN-WILLIAMS COMPANY will be
held in the Landmark Conference Center, 927 Midland Building, 101 Prospect
Avenue, N.W., Cleveland, Ohio on Wednesday, April 24, 2002 at 9:00 A.M., local
time, for the following purposes:
1. To fix the number of directors of Sherwin-Williams at eleven and to
elect eleven directors to hold office until the next Annual Meeting of
Shareholders and until their successors are elected;
2. To approve The Sherwin-Williams Company 2003 Stock Plan; and
3. To transact such other business as may properly come before the Annual
Meeting.
Shareholders of record at the close of business on February 25, 2002 are
the only shareholders entitled to notice of and to vote at the Annual Meeting.
This year, we are again offering shareholders of record the convenience of
voting electronically by the Internet or telephone. We encourage you to vote
electronically and help us save money. If you vote by the Internet or telephone,
you should not return your proxy card. If you choose to vote by mail, please
sign, date and return your proxy card in the envelope provided.
L. E. STELLATO
Secretary
101 Prospect Avenue, N.W.
Cleveland, Ohio 44115-1075
March 14, 2002
YOUR VOTE IS IMPORTANT!
WHETHER OR NOT YOU PLAN TO ATTEND THE ANNUAL MEETING, PLEASE PROMPTLY VOTE
BY THE INTERNET, BY TELEPHONE OR BY COMPLETING AND RETURNING THE ENCLOSED PROXY
CARD. VOTING EARLY WILL HELP AVOID ADDITIONAL SOLICITATION COSTS AND WILL NOT
PREVENT YOU FROM VOTING IN PERSON AT THE ANNUAL MEETING IF YOU WISH TO DO SO.
THE SHERWIN-WILLIAMS COMPANY
101 PROSPECT AVENUE, N.W.
CLEVELAND, OHIO 44115-1075
PROXY STATEMENT
March 14, 2002
PRELIMINARY
The enclosed proxy is requested by the Board of Directors in connection
with the Annual Meeting of Shareholders to be held April 24, 2002 for the
purpose of considering and acting upon the matters specified in the foregoing
Notice of Annual Meeting of Shareholders. This Proxy Statement is first being
mailed on approximately March 14, 2002.
ANNUAL REPORT
Sherwin-Williams' Annual Report to Shareholders for the year ended December
31, 2001 is enclosed with this Proxy Statement. Additional financial and other
reports may be submitted at the Annual Meeting, but it is not intended that any
action will be taken relating to those reports.
VOTING PROCEDURES
WHO IS ENTITLED TO VOTE?
Only record holders of common stock and convertible participating serial
preferred stock at the close of business on February 25, 2002, the record date,
are entitled to vote at the Annual Meeting. At the close of business on the
record date, 152,564,448 shares of common stock and 141,456 shares of
convertible participating serial preferred stock were outstanding. Each share
owned on the record date is entitled to one vote.
HOW DO I VOTE?
If you are a shareholder of record, you can vote in person at the Annual
Meeting or you can vote on the Internet, by telephone or by signing and mailing
your proxy card in the enclosed envelope. Detailed instructions for Internet and
telephone voting are attached to your proxy card.
If you are a shareholder of record and you vote by the Internet or
telephone, your vote must be received by 5:00 p.m. E.S.T. on April 23, 2002; you
should not return your proxy card. If you hold shares through a broker or other
nominee, you should complete, sign and date the voting instruction card provided
to you by your broker or nominee or vote by the Internet or telephone as
permitted by your broker or nominee.
Shareholders of record may also be represented by another person present at
the Annual Meeting by signing a proxy designating such person to act on your
behalf. If you hold shares through a broker or nominee, you may not vote in
person at the Annual Meeting unless you have obtained a signed proxy from your
broker or nominee giving you the right to vote your shares.
HOW DO I VOTE IF I AM A PARTICIPANT IN THE STOCK OWNERSHIP AND AUTOMATIC
DIVIDEND REINVESTMENT PLAN OR THE EMPLOYEE STOCK PURCHASE AND SAVINGS PLAN?
If you are a participant in one of these plans, your proxy card also serves
as voting instructions for the number of shares which you are entitled to direct
the vote under each plan. You may vote your shares by the Internet, telephone or
mail in the same manner outlined above. If you are a participant in the Employee
Stock Purchase and Savings Plan, your vote must be received by the close of
business on April 18, 2002.
1
WHAT ARE THE VOTING RECOMMENDATIONS OF THE BOARD OF DIRECTORS?
The Board of Directors recommends that you vote FOR fixing the number of
directors at eleven and electing the eleven nominees for directors and FOR
approval of the 2003 Stock Plan.
The Board of Directors is not aware of any other matters that will be
brought before the Annual Meeting for action. However, if any other matters that
may properly come before the Annual Meeting are brought up for vote, it is
intended that the proxy holders may vote or act according to their judgment.
WHAT CONSTITUTES A QUORUM FOR THE ANNUAL MEETING?
For a quorum, there must be present, in person or by proxy, shareholders of
record entitled to exercise not less than fifty percent of the voting power of
Sherwin-Williams. Proxy cards marked as withholding authority, as well as proxy
cards containing abstentions and "broker non-votes," will be treated as present
for purposes of determining a quorum. A "broker non-vote" occurs when a broker
or other nominee holding shares for a beneficial owner does not vote on a
particular proposal because the broker or nominee does not have discretionary
voting power for that proposal and has not received voting instructions from the
beneficial owner.
WHAT VOTE IS REQUIRED TO APPROVE EACH PROPOSAL?
The proposal to fix the number of directors at eleven requires the
affirmative vote of the holders of a majority of the shares present, in person
or by proxy, and entitled to vote at the Annual Meeting. The nominees receiving
the greatest number of votes will be elected. A proxy card marked as withholding
authority with respect to the election of one or more directors will not be
voted with respect to the director or directors indicated, although it will be
counted for quorum purposes.
The proposal to approve the 2003 Stock Plan requires the affirmative vote
of the holders of a majority of the shares present, in person or by proxy, and
entitled to vote at the Annual Meeting. A proxy card marked as abstaining with
respect to this proposal will be treated as present and entitled to vote and
will be counted for quorum purposes, but will not be counted as a vote for
purposes of this proposal. Accordingly, an abstention will have the effect of a
negative vote. A broker non-vote will not be treated as present and entitled to
vote on this proposal and, therefore, will not be counted as a vote for purposes
of this proposal, although it will be counted for quorum purposes.
All other proposals and other business as may properly come before the
Annual Meeting require the affirmative vote of the holders of a majority of the
shares present, in person or by proxy, and entitled to vote at the Annual
Meeting, except as otherwise required by statute or Sherwin-Williams' Amended
Articles of Incorporation.
The proxy holders will vote your shares in accordance with your directions.
If you sign and return your proxy card, but do not properly direct how your
shares should be voted on a proposal, the proxy holders will vote your shares
FOR fixing the number of directors at eleven and electing the eleven nominees
for directors, FOR approval of the 2003 Stock Plan, and in the proxy holder's
discretion upon such other business as may properly come before the Annual
Meeting. If you do not timely vote, the proxy holders cannot vote your shares
(or, in the case of the Employee Stock Purchase and Savings Plan, your shares
will be voted in the same proportion as the trustee votes those shares for which
it receives proper instructions). Any unallocated shares held in the Employee
Stock Purchase and Savings Plan also will be voted by the trustee in the same
proportion as the trustee votes those shares for which it receives proper
instructions.
CAN I REVOKE OR CHANGE MY VOTE AFTER I SUBMIT MY PROXY?
Yes. You can revoke or change your vote before the proxy holders vote your
shares by timely:
- Filing a written revocation with Sherwin-Williams' Vice President,
General Counsel and Secretary;
2
- Returning a later signed and dated proxy card;
- Entering a new vote by the Internet or telephone; or
- Voting in person at the Annual Meeting.
ELECTION OF DIRECTORS (PROPOSAL 1)
At the Annual Meeting, the number of directors is to be fixed at eleven,
and eleven directors are to be elected to hold office until the next Annual
Meeting of Shareholders and until their successors are elected. The nominees are
listed below. Should any nominee decline or be unable to accept such nomination
or be unable to serve, an event which management does not now expect, the Board
of Directors reserves the right in its discretion to substitute another person
as a nominee or to reduce the number of nominees. In this event, the proxy
holders may vote in their discretion for any substitute nominee proposed by the
Board of Directors unless you indicate otherwise.
All of the nominees currently are directors of Sherwin-Williams. All of the
nominees were elected by the shareholders at the 2001 Annual Meeting, except for
Mr. McCullough who was appointed a director by unanimous action of the Board of
Directors on February 6, 2002. The following is information regarding each
nominee:
JAMES C. BOLAND
President and Chief Executive Officer,
CAVS/Gund Arena Company
Director since 1998
James C. Boland, 62, has served as President and Chief Executive Officer of
CAVS/Gund Arena Company (the Cleveland Cavaliers and the Cleveland Rockers
professional basketball teams and Gund Arena) since January 1998. Prior to his
retirement from Ernst & Young in September 1998, Mr. Boland served for 22 years
as a partner of Ernst & Young in various roles including Vice Chairman and
Regional Managing Partner as well as a member of the firm's Management Committee
from 1988 to 1996 and as Vice Chairman of National Accounts from 1997 to his
retirement. Mr. Boland is also a Director of Invacare Corporation and is a
Trustee of Leadership Cleveland, the Great Lakes Science Center, Bluecoats, Inc.
and The 50 Club of Cleveland.
JOHN G. BREEN
Retired, Former Chairman, Chief
Executive Officer and President,
Sherwin-Williams
Director since 1979
John G. Breen, 67, prior to his retirement in April 2000, served as Chairman of
Sherwin-Williams since April 1980. Mr. Breen served as Chief Executive Officer
of Sherwin-Williams from January 1979 to October 1999 and President of
Sherwin-Williams from March 1999 to October 1999. Mr. Breen is also a Director
of National City Corporation, MeadWestvaco Corporation, Parker-Hannifin
Corporation, The Goodyear Tire and Rubber Company and The Stanley Works. Mr.
Breen is a Trustee of The Achievement Centers for Children, Catholic Charities
Corporation, John Carroll University, the Musical Arts Association (The
Cleveland Orchestra) and University Hospitals of Cleveland, and is a Member of
the Visiting Committee of Case Western Reserve University School of Medicine.
DUANE E. COLLINS
Chairman,
Parker-Hannifin Corporation
Director since 1996
Duane E. Collins, 65, has served as Chairman of Parker-Hannifin Corporation
(manufacturer of motion control products) since October 1999. Mr. Collins served
as Chief Executive Officer of Parker-Hannifin from July 1993 to June 2001 and
President of Parker-Hannifin from July 1993 to February 2000. Mr. Collins is
also a Director of MeadWestvaco Corporation and National City Bank, is a Trustee
of the Cleveland YMCA and University Hospitals Health System (Cleveland), and is
a Member of the Visiting Committee of Case Western Reserve University
Weatherhead School of Management.
CHRISTOPHER M. CONNOR
Chairman and Chief Executive Officer,
Sherwin-Williams
Director since 1999
Christopher M. Connor, 45, has served as Chairman of Sherwin-Williams since
April 2000
3
and Chief Executive Officer of Sherwin-Williams since October 1999. Mr. Connor
served as Vice Chairman of Sherwin-Williams from October 1999 to April 2000,
President, Paint Stores Group of Sherwin-Williams from August 1997 to October
1999 and President & General Manager, Diversified Brands Division of
Sherwin-Williams from April 1994 to August 1997. Mr. Connor has been with
Sherwin-Williams since 1983 in roles of increasing responsibility. Mr. Connor is
also a Director of National City Bank and is a Trustee of Keep America
Beautiful, University Hospitals of Cleveland, The Catholic Diocese of Cleveland
Foundation, the Musical Arts Association (The Cleveland Orchestra) and Walsh
Jesuit High School.
DANIEL E. EVANS
Retired, Former Chairman, Chief
Executive Officer and Secretary,
Bob Evans Farms, Inc.
Director since 1990
Daniel E. Evans, 65, prior to his retirement in April 2001, served as Chairman
of Bob Evans Farms, Inc. (food products and restaurants) since 1971. Mr. Evans
served as Chief Executive Officer and Secretary of Bob Evans Farms from 1971 to
April 2000. Mr. Evans is also a Director of Evans Enterprises, Inc., Motorists
Mutual Insurance Company and National City Corporation.
ROBERT W. MAHONEY
Retired, Former Chairman, Chief
Executive Officer and President,
Diebold, Incorporated
Director since 1995
Robert W. Mahoney, 65, prior to his retirement in April 2000, served as Chairman
of Diebold, Incorporated (manufacturer of financial self-service transaction
systems and security products) since April 1988. Mr. Mahoney served as Chief
Executive Officer of Diebold from April 1988 to November 1999 and President of
Diebold from July 1993 to November 1996. Mr. Mahoney is also the Deputy Chairman
of the Federal Reserve Bank of Cleveland, is a Director of The Timken Company,
is a Trustee of Mercy Medical Center (Canton, Ohio), Mount Union College and the
Professional Football Hall of Fame, and is a Member of the Stark (County, Ohio)
Development Board and the Chamber of Commerce Leadership Canton (Ohio) Advisory
Board.
GARY E. MCCULLOUGH
Senior Vice President - Americas,
Wm. Wrigley Jr. Company
Director since 2002
Gary E. McCullough, 43, has served as Senior Vice President - Americas of Wm.
Wrigley Jr. Company (manufacturer and marketer of chewing gums and confectionery
products) since March 2000. Mr. McCullough served in a variety of marketing and
management positions at The Procter & Gamble Company, in the United States and
abroad, from June 1987 to March 2000. Immediately prior to joining Wrigley, Mr.
McCullough served as General Manager, North America Home Care Category from
December 1998 to March 2000, Marketing Director, Juice Products Category from
September 1996 to December 1998, and Marketing Director, Laundry & Cleaning
Products, Venezuela from December 1995 to September 1996. Mr. McCullough is a
Trustee of Keep America Beautiful and is a member of the Board of Advisors of
the National Industries for the Blind.
A. MALACHI MIXON, III
Chairman and Chief Executive Officer,
Invacare Corporation
Director since 1993
A. Malachi Mixon, III, 61, has served as Chief Executive Officer of Invacare
Corporation (manufacturer and distributor of home health care products) since
January 1980 and Chairman of Invacare since September 1983. Mr. Mixon served as
President of Invacare from January 1980 to November 1996. Mr. Mixon is also a
Director of The Lamson and Sessions Co., is Chairman of The Cleveland Clinic
Foundation and the Cleveland Institute of Music, and is a Trustee of Case
Western Reserve University.
CURTIS E. MOLL
Chairman and Chief Executive Officer,
MTD Products, Inc.
Director since 1997
Curtis E. Moll, 62, has served as Chairman and Chief Executive Officer of MTD
Products, Inc. (manufacturer of outdoor power equipment and tools, dies and
stampings for the automotive
4
industry) since October 1980. Mr. Moll is also a Director of AGCO Corporation
and Shiloh Industries, Inc.
JOSEPH M. SCAMINACE
President and Chief Operating Officer,
Sherwin-Williams
Director since 1999
Joseph M. Scaminace, 48, has served as President and Chief Operating Officer of
Sherwin-Williams since October 1999. Mr. Scaminace served as President, Consumer
Group of Sherwin-Williams from July 1998 to October 1999, President & General
Manager, Coatings Division of Sherwin-Williams from June 1997 to July 1998, and
President & General Manager, Automotive Division of Sherwin-Williams from April
1994 to June 1997. Mr. Scaminace is also a Trustee of The Cleveland Clinic
Foundation, Marymount Health Care Systems and Womankind.
RICHARD K. SMUCKER
President and Co-Chief Executive Officer,
The J.M. Smucker Company
Director since 1991
Richard K. Smucker, 53, has served as Co-Chief Executive Officer of The J.M.
Smucker Company (makers of food products) since February 2001 and President of
J.M. Smucker since January 1987. Mr. Smucker is also a Director of J.M. Smucker,
International Multifoods Corporation and Wm. Wrigley Jr. Company, and is a
Trustee of the Musical Arts Association (The Cleveland Orchestra).
COMPENSATION OF DIRECTORS
Currently, each director who is not a Sherwin-Williams employee receives an
annual retainer of $35,000 earned and payable monthly. In addition, each such
director receives $1,750 for each meeting of the Board of Directors or Committee
of the Board of Directors that such director attends or $2,000 for each meeting
of a Committee of the Board of Directors that such director chairs. Officers of
Sherwin-Williams who also serve as directors do not receive any compensation
specifically for services as a member of the Board of Directors or any
Committee. Directors are permitted to defer all or a portion of their fees under
the Director Deferred Fee Plan. Deferred fees may be invested in either a common
stock account, a shadow stock account or an interest bearing cash account.
In addition, directors who are not Sherwin-Williams employees may receive
stock options and restricted stock under the 1997 Stock Plan for Nonemployee
Directors. This plan was approved by the shareholders at the 1997 Annual
Meeting. During 2001, each nonemployee director received a grant of 2,000
options at an exercise price equal to the fair market value of common stock on
the date of grant. One third of the options become exercisable on each of the
first, second and third anniversary dates of the date of grant. No shares of
restricted stock were awarded to any nonemployee director during 2001.
Mr. Breen retired as Chairman of Sherwin-Williams in April 2000. Following
his retirement, Mr. Breen remained as a director for which he receives
compensation in an amount equal to the compensation received by the other
nonemployee directors. He also entered into a consulting agreement with
Sherwin-Williams. Under the agreement, Mr. Breen agreed to perform business and
community-related consulting services which enhance the reputation and further
the interests of Sherwin-Williams. The agreement has a term ending on December
31, 2004. As compensation for the consulting services, Mr. Breen received a fee
of $138,600 in 2001 and will receive an annual fee for each remaining year of
the term in the amount of $152,500 for 2002, $167,700 for 2003 and $184,500 for
2004. In the event of a change of control of Sherwin-Williams or Mr. Breen's
death prior to the end of the term, any unpaid fees with respect to the
remaining period of the term will be immediately due and payable. Mr. Breen also
receives office space, part-time administrative assistance and maintenance of a
home security system. Mr. Breen is reimbursed for all air fare expenses
associated with his performance of consulting services, but he is responsible
for all other associated expenses.
MEETINGS AND COMMITTEES OF THE BOARD OF DIRECTORS
The Board of Directors held six meetings during 2001. Each director
attended at least
5
75% of the meetings of the Board of Directors and committees on which he served.
The Board of Directors has established, among other committees, an Audit
Committee, a Board Composition Committee and a Compensation and Management
Development Committee. The functions and members of these Committees are as
follows:
AUDIT. The primary function of the Audit Committee is to assist the Board
of Directors in fulfilling the Board of Directors' oversight responsibilities on
matters relating to: Sherwin-Williams' financial reports and other financial
information provided by Sherwin-Williams to any governmental body or the public;
Sherwin-Williams' systems of internal controls regarding financing, accounting
and legal compliance; Sherwin-Williams' auditing, accounting and financial
reporting processes generally; and such other matters as may be specifically
delegated to the Committee by the Board of Directors. The Board of Directors has
adopted a written charter for the Committee. A copy of the charter was attached
to last year's proxy statement.
The Audit Committee met twice during 2001 and is currently composed of four
directors: J. C. Boland, R. W. Mahoney, C. E. Moll and R. K. Smucker (Chairman).
Each member of the Committee is independent as defined in the listing standards
of the New York Stock Exchange.
BOARD COMPOSITION. The Board Composition Committee develops plans for the
composition of the Board of Directors. Matters considered by this Committee
include the size of the Board of Directors and the number of independent
directors, as well as the skills and disciplines desired as represented by
individual directors. The Committee also is charged with the responsibility to
conduct searches for prospective members, interview candidates and make
selections and recommendations to the Board of Directors. The Committee has not
undertaken to consider nominees recommended by shareholders but has and may
continue to employ professional search firms to assist it in identifying
potential members of the Board of Directors with the desired skills and
disciplines.
The Board Composition Committee met twice in 2001 and is currently composed
of three directors: J. G. Breen, D. E. Collins and A. M. Mixon, III (Chairman).
COMPENSATION AND MANAGEMENT DEVELOPMENT. The Compensation and Management
Development Committee is primarily responsible for matters relating to
Sherwin-Williams' management compensation programs and management succession
planning. Specifically, the Committee establishes general policies on an annual
basis for changes in compensation for all key employees, reviews and approves
the compensation for the Chairman and Chief Executive Officer and the other
executive officers and key employees; administers the Management Incentive Plan;
authorizes and approves grants of stock options, stock appreciation rights and
restricted stock under the 1994 Stock Plan and the 1997 Stock Plan for
Nonemployee Directors; authorizes actions relating to the employee benefit
plans, programs and arrangements; and reviews management programs for developing
competent managers for present and future needs.
The Compensation and Management Development Committee met three times
during 2001 and is currently composed of four independent directors: J. C.
Boland, D. E. Collins (Chairman), D. E. Evans and R. W. Mahoney.
AUDIT COMMITTEE REPORT
Management has the primary responsibility for the integrity of
Sherwin-Williams' financial information. Ernst & Young LLP, Sherwin-Williams'
independent auditors, is responsible for conducting independent audits of
Sherwin-Williams' financial statements in accordance with generally accepted
auditing standards and expressing an opinion on the financial statements based
upon those audits. The Audit Committee is responsible for overseeing the conduct
of these activities by management and Ernst & Young LLP.
As part of its responsibility, the Audit Committee has reviewed and
discussed the audited financial statements with management and Ernst & Young
LLP. The Audit Committee also has discussed with Ernst & Young LLP the matters
required to be discussed by Statement
6
on Auditing Standards No. 61 (Communication with Audit Committees). The Audit
Committee has received the written disclosures and the letter from Ernst & Young
LLP required by Independence Standards Board Standard No. 1 (Independence
Discussions with Audit Committees) and has discussed with Ernst & Young LLP that
firm's independence.
Based upon these reviews and discussions, the Audit Committee recommended
to the Board of Directors that the audited financial statements be included in
Sherwin-Williams' Annual Report on Form 10-K for the year ended December 31,
2001 for filing with the Securities and Exchange Commission.
AUDIT COMMITTEE
R.K. Smucker, Chairman
J.C. Boland
R.W. Mahoney
C.E. Moll
MATTERS RELATING TO
THE INDEPENDENT AUDITORS
APPOINTMENT OF ERNST & YOUNG LLP. The Board of Directors has appointed
Ernst & Young LLP to examine Sherwin-Williams' consolidated financial statements
for the fiscal year ending December 31, 2002. Ernst & Young LLP acted as
Sherwin-Williams' independent auditors for the fiscal year ended December 31,
2001. Representatives of Ernst & Young LLP are expected to be present at the
Annual Meeting and will have an opportunity to make a statement if they wish and
to respond to appropriate shareholder questions.
AUDIT FEES. The aggregate fees billed for professional services rendered
for the audit of Sherwin-Williams' consolidated financial statements for the
fiscal year ended December 31, 2001 and for the reviews of Sherwin-Williams'
consolidated financial statements included in its Quarterly Reports on Form 10-Q
for that fiscal year were $579,000.
FINANCIAL INFORMATION SYSTEMS DESIGN AND IMPLEMENTATION FEES. During 2001,
Ernst & Young LLP did not perform any services for Sherwin-Williams relating to
the design or implementation of Sherwin-Williams' financial information systems.
ALL OTHER FEES. During 2001, Ernst & Young LLP billed $821,520 in aggregate
fees for all services rendered by Ernst & Young, other than the audit services
described above. The Audit Committee of the Board of Directors has considered
whether providing these non-audit services is compatible with maintaining Ernst
& Young LLP's independence.
COMPENSATION COMMITTEE
INTERLOCKS AND
INSIDER PARTICIPATION
The following directors served on the Compensation and Management
Development Committee of Sherwin-Williams' Board of Directors during 2001: J. C.
Boland, D. E. Collins, D. E. Evans, R. W. Mahoney and W. G. Mitchell. Mr. Breen,
who retired as Chairman of Sherwin-Williams in April 2000, serves on the
Compensation and Management Development Committee of the Board of Directors of
Parker-Hannifin Corporation, of which Mr. Collins is Chairman.
COMPENSATION AND MANAGEMENT
DEVELOPMENT COMMITTEE
REPORT ON EXECUTIVE COMPENSATION
MANAGEMENT COMPENSATION PROGRAM. Sherwin-Williams' management compensation
program is administered by the Compensation and Management Development Committee
of the Board of Directors. The Committee is composed of four independent
directors and reports to the Board of Directors on all compensation matters
regarding certain members of Sherwin-Williams' management, including the
executive officers. The executive officers are identified in Sherwin-Williams'
2001 Annual Report to Shareholders. The program is designed to attract, motivate
and retain key executives and to establish and maintain a performance and
achievement-oriented environment. The program consists of both cash and
equity-based compensation. The program provides for:
- competitive base salary levels which reflect, in part, individual
performance,
- additional annual incentive compensation based on the achievement of
financial and other performance goals, and
7
- long-term stock-based incentive opportunities.
The annual base salary, annual incentive compensation and long-term
incentive opportunities are intended to be competitive with market base salary
and incentive compensation opportunities. The Committee utilizes data from
various commercially available executive compensation surveys in order to
identify, on an annual basis, the base salary and incentive opportunities
available at manufacturing companies with comparable sales. The Committee
believes that these companies likely compete with Sherwin-Williams for executive
talent. These companies may include some of the companies comprising the peer
group identified in the performance graph if such companies participated in one
or more of the compensation surveys. For the various components of compensation,
the Committee uses the median compensation paid to executive officers holding
equivalent positions or having similar responsibilities in manufacturing
companies with comparable sales. The amount of compensation paid to the
executive officers is not based upon the cumulative total return on
Sherwin-Williams common stock as reflected in the performance graph.
BASE SALARY. Annual cash compensation consists, in part, of a base salary.
With regard to base salary, a salary range for each executive officer is
approved on the basis of such person's position and level of responsibility by
using the compensation surveys, with the median market base salary from the
surveys approximating the midpoint of the range. Once a range is formulated,
salary levels are based upon the executive officer's performance and, to a
lesser extent, tenure in the particular position. With regard to performance,
the executive officer's performance for the prior year is reviewed based on
performance criteria (both quantitative and qualitative) which vary by executive
officer and which usually relate to the particular business unit or function for
which such person has responsibility. The base salary of each executive officer
is reviewed and approved annually.
ANNUAL INCENTIVE COMPENSATION. Annual cash compensation also consists of
the opportunity to earn additional compensation under the Management Incentive
Plan. All of the executive officers participate in the Management Incentive
Plan. In determining the amount of annual incentive compensation paid to any of
the executive officers, great emphasis is placed on establishing incentive
opportunities which are directly linked with Sherwin-Williams' performance and
the maximization of shareholder value. The Committee establishes a threshold
goal of increased company earnings, and 75% of this earnings increase must be
met before incentive compensation is paid, subject to adjustments for
non-recurring or unusual items and awards for individual performance. In its
discretion, the Committee decided to award bonuses to executive officers for
2001, taking into consideration individual performance.
Annual incentive compensation awarded to an executive officer is also
determined by using the median incentive compensation (identified from the
compensation surveys), which is generally equivalent to the amount an executive
officer could receive under the Management Incentive Plan if a 100% average of
Sherwin-Williams' and the individual's goals are attained. Under the Management
Incentive Plan, annual bonus awards for the executive officers range from zero,
if less than a 75% average of the stated goals are reached, to between 45% and
75% of the executive officer's base salary (depending upon the executive
officer's position) if a 100% average of the stated goals are attained. In the
event Sherwin-Williams and an executive officer exceed a 100% average of the
stated goals, incentive compensation can be awarded up to an aggregate maximum
amount of 70% to 110% of the executive officer's base salary (depending upon
position). Consequently, incentive compensation paid to an executive officer in
any year may exceed the median incentive compensation determined by the
compensation surveys.
Decisions on annual incentive compensation awarded to an executive officer
are based upon financial performance goals for each Management Incentive Plan
year and the accomplishment by the executive officer of individual performance
goals. Individual performance goals vary by executive officer and usually relate
to the particular business unit or function for which such person has
8
responsibility. The financial performance goals are generally weighted more
heavily.
LONG-TERM INCENTIVE COMPENSATION. Long-term incentive compensation may be
awarded to any one or all of the executive officers under the 1994 Stock Plan.
All of the executive officers participate in the 1994 Stock Plan. Under the 1994
Stock Plan, the Committee may grant stock options to the executive officers
based on competitive market practices. Competitive market practices are
determined by the compensation surveys mentioned above. The Committee grants
stock options based upon the median market value of the underlying stock
relating to stock options that comparable companies have been granting to their
executive officers. The specific number of stock options granted to an executive
officer is based upon the executive officer's position and level of
responsibility. The option exercise price is equal to the fair market value of
Sherwin-Williams common stock on the date options are granted. Stock options
typically vest at the rate of one-third per year for three years (beginning one
year from the date of grant) and expire ten years from the date of grant.
Awards of restricted stock under the 1994 Stock Plan, which are subject to
a "substantial risk of forfeiture," may be granted to the executive officers.
The granting of restricted stock is determined in the same manner that the
granting of stock options is determined. If granted, shares of restricted stock
vest in accordance with performance and time restrictions. The number of shares
of restricted stock which may actually vest at the end of the restriction period
depends upon Sherwin-Williams' relative return on average shareholder equity
versus a group of peer companies. The companies that comprise this group of peer
companies (for the most recent grant) are the same companies that comprise the
peer group identified in the performance graph, except that the restricted stock
peer group does not include two companies which have been acquired by other
companies. Depending on Sherwin-Williams' performance at the end of the
restriction period, from 0% to 100% of the shares of restricted stock may vest.
The restriction period is typically four years from the date of grant of the
restricted stock. The amount of outstanding stock options and shares of
restricted stock generally is not considered by the Committee in making awards
of stock options and restricted stock.
CHIEF EXECUTIVE OFFICER COMPENSATION. Mr. Connor's compensation during 2001
consisted of the same elements as the other executive officers - base salary,
annual incentive compensation and long-term incentive compensation. The
Committee determined Mr. Connor's compensation for 2001 based on a number of
factors and criteria. His base salary range was determined using the median base
salary of chairmen and chief executive officers for manufacturing companies
having comparable sales as Sherwin-Williams. Mr. Connor's base salary within the
range was established based upon a review by the Committee of Mr. Connor's 2000
performance (which was measured, in part, by Sherwin-Williams' 2000
performance). For 2001, the average salary increase given generally to
Sherwin-Williams' salaried employees was 4%, and the range of potential
increases was 0% to 8.5%. In February 2001, Mr. Connor received a base salary
increase of 4%, bringing his base salary to $832,000. Mr. Connor's increase was
based primarily upon the Committee's evaluation of his 2000 performance relating
to the financial and other performance measures set forth in the next paragraph.
In addition, in 2001 Mr. Connor earned a bonus of $570,000 as annual
incentive compensation under the Management Incentive Plan. The amount of Mr.
Connor's bonus was based primarily upon Sherwin-Williams' results for 2001
financial performance goals relating to sales, earnings per share, return on
stockholders' equity, return on sales, cash flow, working capital as a percent
of sales, and long-term strategic planning.
In 2001, Mr. Connor was awarded 250,000 stock options and 50,000 shares of
restricted stock. In determining the number of stock options and shares of
restricted stock awarded to Mr. Connor, the Committee also identified the median
market value of the underlying shares relating to stock options and of shares of
restricted stock which comparable companies granted to their chief executive
officers. The amount of outstanding stock options and shares of restricted stock
generally is
9
not considered by the Committee in making awards of stock options and restricted
stock.
POLICY ON DEDUCTIBILITY OF COMPENSATION. Section 162(m) of the Internal
Revenue Code generally provides that certain compensation in excess of $1
million per year paid to a company's chief executive officer and any of its four
other highest paid executive officers is not deductible to a company unless the
compensation qualifies for an exception. Section 162(m) provides an exception to
the deductibility limit for performance-based compensation if certain procedural
requirements, including shareholder approval of the material terms of the
performance goal, are satisfied. The Committee believes that grants of options,
stock appreciation rights and restricted stock under the 1994 Stock Plan qualify
for full deductibility under Section 162(m). Compensation paid under the
Management Incentive Plan does not qualify for the exemption for
performance-based compensation. At this time, based upon Sherwin-Williams'
current compensation structure, the Committee believes it is in the best
interests of Sherwin-Williams and its shareholders for the Committee to retain
flexibility in awarding incentive compensation under the Management Incentive
Plan which does not qualify for the exemption for performance-based
compensation. The Committee will continue to review and evaluate, as necessary,
the impact of Section 162(m) on Sherwin-Williams' compensation programs.
COMPENSATION AND MANAGEMENT
DEVELOPMENT COMMITTEE
D.E. Collins, Chairman
J.C. Boland
D.E. Evans
R.W. Mahoney
10
PERFORMANCE GRAPH
The following graph compares the cumulative total shareholder return on
Sherwin-Williams common stock with the cumulative total return of the companies
listed on the Standard & Poor's 500 Stock Index and a peer group of companies
selected on a line-of-business basis. The "Peer Group" is comprised of the
following companies: Akzo Nobel nv, Armstrong Holdings, Inc., BASF Corporation,
Ferro Corporation, H.B. Fuller Company, Genuine Parts Company, The Home Depot,
Inc., Imperial Chemicals Industries PLC, Lilly Industries, Inc.*, Lowe's
Companies, Inc., Masco Corporation, Morton International, Inc.*, Newell
Rubbermaid Inc., PPG Industries, Inc., RPM, Inc., The Stanley Works, USG
Corporation and The Valspar Corporation. An asterisk indicates that the company
is included in the performance graph through the last day it was publicly
traded.
COMPARISON OF FIVE YEAR CUMULATIVE TOTAL RETURN
AMONG SHERWIN-WILLIAMS, S&P 500 AND THE PEER GROUP
[COMPARISON OF FIVE YEAR CUMULATIVE RETURN GRAPH]
1996 1997 1998 1999 2000 2001
SHERWIN-WILLIAMS $100 $101 $108 $ 79 $101 $108
S&P 500 $100 $133 $171 $208 $189 $166
PEER GROUP $100 $134 $180 $239 $182 $209
Assumes $100 invested on December 31, 1996 in Sherwin-Williams common stock, the
S&P 500 and the Peer Group, including reinvestment of dividends, through
December 31, 2001.
11
SUMMARY COMPENSATION TABLE
LONG TERM
ANNUAL COMPENSATION COMPENSATION AWARDS
----------------------------- -----------------------
RESTRICTED SECURITIES
STOCK UNDERLYING ALL OTHER
NAME AND AWARD(S) OPTIONS/ COMPEN-
PRINCIPAL POSITION YEAR SALARY ($) BONUS ($) ($)(2,3) SARS (#) SATION($)(4)
------------------ ---- ---------- --------- ---------- ---------- ------------
C. M. Connor(1) 2001 828,310 570,000 1,301,500 250,000 216,436
Chairman and 2000 749,821 490,000 -0- 200,000 155,996
Chief Executive Officer 1999 467,248 510,000 779,375 390,000 123,157
J. M. Scaminace(1) 2001 603,655 450,000 728,840 125,000 154,592
President and Chief 2000 579,214 390,000 -0- 100,000 141,189
Operating Officer 1999 449,941 430,000 580,000 290,000 121,130
L. E. Stellato 2001 318,600 210,000 182,210 30,000 77,560
Vice President, General 2000 306,238 200,000 -0- 30,000 86,217
Counsel and Secretary 1999 291,652 240,000 177,625 55,000 88,534
J. G. Morikis(1) 2001 331,320 179,000 338,390 60,000 77,780
President, 2000 310,617 168,000 -0- 60,000 275,959
Paint Stores Group 1999 217,669 175,000 251,938 125,000 42,931
C. G. Ivy 2001 291,175 200,000 182,210 30,000 64,436
Senior Vice President -- 2000 279,968 188,000 -0- 30,000 70,563
Corporate Planning and 1999 268,900 220,000 177,625 55,000 72,988
Development
L. J. Pitorak(5) 2001 406,224 195,000 338,390 -0- 88,653
Former Senior Vice 2000 396,552 240,000 -0- 60,000 114,217
President -- Finance, 1999 377,741 306,000 253,750 112,000 103,427
Treasurer and Chief Financial
Officer
---------------
(1) Mr. Connor, previously President, Paint Stores Group, became Chief Executive
Officer in October 1999 and Chairman in April 2000. Mr. Scaminace,
previously President, Consumer Group, became President and Chief Operating
Officer in October 1999. Mr. Morikis, previously President & General
Manager, Eastern Division, Paint Stores Group, became President, Paint
Stores Group in October 1999.
(2) The value of restricted stock indicated in the table is equal to the number
of shares of restricted stock granted during such years multiplied by the
closing price of common stock on the date of grant. At December 31, 2001,
the aggregate number and value (calculated by using the closing price of
common stock on December 31, 2001) of shares of restricted stock held by
Messrs. Connor, Scaminace, Stellato, Morikis, Ivy and Pitorak were 85,000
shares with a value of $2,337,500, 53,000 shares with a value of $1,457,500,
14,000 shares with a value of $385,000, 24,000 shares with a value of
$660,000, 14,000 shares with a value of $385,000, and 23,000 shares with a
value of $632,500, respectively. The number of shares and values indicated
are not necessarily indicative of the actual number of shares and values
which may be realized by the named executive officers.
(3) Dividends are paid on all restricted stock at the same rate as paid on
common stock.
(4) The amounts disclosed in this column for 2001 include: (a) company
contributions in the amount of $8,500 for each of Messrs. Connor, Scaminace,
Stellato, Morikis, Ivy and Pitorak under the Pension Investment Plan, a
defined contribution plan; (b) company contributions in the amounts of
$54,491, $41,961, $18,812, $15,781, $16,498 and $26,628 for Messrs. Connor,
Scaminace, Stellato, Morikis, Ivy and Pitorak, respectively, under the
Pension Investment Plan Equalization Program, a defined contribution plan;
(c) company contributions in the amount of $7,276 for each of Messrs.
Connor, Scaminace, Stellato, Morikis, Ivy and Pitorak under the Employee
Stock Purchase and Savings Plan, a defined contribution plan; (d) company
contributions in the amounts of $89,132, $67,770, $32,670, $29,576, $29,444
and $43,374 for Messrs. Connor, Scaminace, Stellato, Morikis, Ivy and
Pitorak, respectively, under the Deferred Compensation Savings Plan, a
defined contribution plan; (e) the dollar value of compensatory split-dollar
life insurance benefits in the amounts of $54,665, $26,693, $8,078 and
$14,704 for Messrs. Connor, Scaminace, Stellato and Morikis, respectively,
under the Executive Life Insurance Plan; and (f) payments by
Sherwin-Williams in the amounts of $2,372, $2,392, $2,224, $1,943, $2,718
and $2,875 for Messrs. Connor, Scaminace, Stellato, Morikis, Ivy and
Pitorak, respectively, for premiums under the Executive Disability Income
Plan.
(5) Mr. Pitorak served as an executive officer until August 2001.
12
OPTION/SAR GRANTS IN LAST FISCAL YEAR
INDIVIDUAL GRANTS
--------------------------------------------------
PERCENT OF
NUMBER OF TOTAL
SECURITIES OPTIONS/ POTENTIAL REALIZABLE VALUE
UNDERLYING SARS AT ASSUMED ANNUAL RATES
OPTIONS/ GRANTED TO OF STOCK PRICE APPRECIATION
SARS EMPLOYEES EXERCISE OR FOR OPTION TERM(4)
GRANTED IN FISCAL BASE PRICE EXPIRATION -----------------------------
(#)(1,2) YEAR ($/SH)(3) DATE 5% ($) 10% ($)
NAME ---------- ---------- ----------- ---------- ------------- -------------
C. M. Connor 250,000 8.18 24.305 10/16/11 3,819,998 9,679,863
J. M. Scaminace 125,000 4.09 24.305 10/16/11 1,909,999 4,839,931
L. E. Stellato 30,000 0.98 24.305 10/16/11 458,400 1,161,584
J. G. Morikis 60,000 1.96 24.305 10/16/11 916,800 2,323,167
C. G. Ivy 30,000 0.98 24.305 10/16/11 458,400 1,161,584
L. J. Pitorak -0- -0- N/A N/A -0- -0-
Value realizable for all
shareholders(5) N/A N/A N/A N/A 2,359,680,326 5,979,928,227
Value realizable for the named
executive officers as a % of
value realizable for all
shareholders N/A N/A N/A N/A 0.32% 0.32%
---------------
(1) One-third of the options granted are exercisable on each of the first,
second and third anniversary dates of the grant.
(2) All options granted become immediately exercisable in full upon (a) a filing
pursuant to any federal or state law in connection with any tender offer for
shares of common stock (other than a tender offer by Sherwin-Williams) or
(b) the signing of any agreement for the merger of Sherwin-Williams into, or
its consolidation with, another corporation or for the sale of substantially
all of the assets of Sherwin-Williams to another corporation; which tender
offer, merger, consolidation or sale, if consummated, would in the opinion
of the Board of Directors likely result in a change in control of
Sherwin-Williams. In the event any such tender offer, merger, consolidation
or sale is abandoned or in the opinion of the Board of Directors is not
likely to be consummated, the Board of Directors may nullify the effect of
the immediately preceding sentence and reinstate the provisions providing
for accrual in installments without prejudice to any exercise of options
that may have occurred prior to such nullification.
(3) The exercise price is equal to the fair market value of common stock on the
date of grant.
(4) The amounts disclosed in these columns, which reflect appreciation of the
price of common stock at 5% and 10% annual rates over the ten year terms of
the options, are not intended to be a forecast of the price of common stock
and are not necessarily indicative of the actual values which may be
realized by the named executive officers or the shareholders. These assumed
rates of 5% and 10% would result in the price of common stock increasing
from $24.305 per share to approximately $39.59 per share and $63.04 per
share, respectively.
(5) The amounts disclosed reflect appreciation of the price of common stock at
5% and 10% annual rates over a ten year period for all shareholders based on
the total number of shares of common stock outstanding on October 17, 2001
(the date on which the options set forth in this table were granted) and
assuming a per share price equal to the exercise price of such options.
13
AGGREGATED OPTION/SAR EXERCISES IN LAST FISCAL YEAR
AND FY-END OPTION/SAR VALUES
NUMBER OF SECURITIES VALUE OF UNEXERCISED
SHARES UNDERLYING UNEXERCISED IN-THE-MONEY OPTIONS/SARS
ACQUIRED ON VALUE OPTIONS/SARS AT FY-END (#) AT FY-END ($)(2)
EXERCISE REALIZED --------------------------- ---------------------------
NAME (#) ($)(1) EXERCISABLE UNEXERCISABLE EXERCISABLE UNEXERCISABLE
---- ----------- ------------- ----------- ------------- ----------- -------------
C. M. Connor 14,158 146,778 429,666 513,334 2,304,995 2,780,347
J. M. Scaminace 33,398 377,219 347,668 288,334 1,738,113 1,555,805
L. E. Stellato 47,600 504,209 97,666 68,334 347,159 363,931
J. G. Morikis 53,333 340,131 93,999 141,668 330,543 805,519
C. G. Ivy 17,000 246,113 128,866 68,334 709,445 363,931
L. J. Pitorak -0- -0- 197,000 77,334 657,414 525,568
---------------
(1) The value realized on the exercise of options is based on the difference
between the exercise price and the fair market value of common stock on the
date of exercise.
(2) The value of unexercised in-the-money options is based on the difference
between the exercise price and the fair market value of common stock on
December 31, 2001.
EMPLOYMENT CONTRACTS,
TERMINATION OF EMPLOYMENT
AND CHANGE-IN-CONTROL
ARRANGEMENTS
MR. IVY'S EMPLOYMENT AGREEMENT. Mr. Ivy has an employment agreement with
Sherwin-Williams. In addition to his basic compensation, incentive compensation,
and participation in employee benefit plans and the 1994 Stock Plan, Mr. Ivy is
entitled to receive, in the event Sherwin-Williams terminates his employment for
any reason, except in the event termination is the result of a change of control
of Sherwin-Williams, an amount equal to one and one-half times the sum of his
annual salary and any bonus paid or payable to him for the preceding year. In
the event termination of employment is the result of a change of control of
Sherwin-Williams, Mr. Ivy is entitled to receive, at the time of his termination
of employment, an amount equal to his annual assured compensation. Annual
assured compensation is defined as the sum of (a) twenty-six times his highest
regular bi-weekly salary in effect within the three year period preceding
termination, plus (b) the greater of the highest bonus paid or payable within
the three year period preceding termination or the bonus he would have received
for the year of termination had he reached 100% of any stated goals (as
explained in the Compensation and Management Development Committee Report on
Executive Compensation). Assuming a termination date of February 28, 2002 as a
result of a change of control, the cash amount payable to Mr. Ivy under this
agreement would have been approximately $522,718. The amount received under this
agreement due to a termination of employment resulting from a change of control
will be offset against the amount payable under the severance pay agreement
described below.
SEVERANCE PAY AGREEMENTS. To ensure continuity and the continued
dedication of key executives during any period of uncertainty caused by the
possible threat of a takeover, Sherwin-Williams has entered into severance pay
agreements with key executives, including each of the executive officers named
in the Summary Compensation Table. In the event there is a change of control of
Sherwin-Williams and the employment of the executive terminates under certain
conditions described in the agreements at any time during the two year period
following a change of control, the executive will receive an agreed upon amount
of severance pay.
For Messrs. Connor and Scaminace, the severance pay agreements provide that
upon termination of employment, whether voluntary or involuntary, unless the
termination is because of death or by Sherwin-Williams for cause, each will
receive accrued salary, bonus
14
and vacation pay. Each executive will also receive a lump sum cash amount equal
to four times the sum of (a) twenty-six times his highest regular bi-weekly
compensation in effect within the three year period preceding termination, plus
(b) the greater of his highest bonus received within the three year period
preceding termination or the bonus he would have received for the year of
termination had he reached 100% of any stated goals (as explained in the
Compensation and Management Development Committee Report on Executive
Compensation). In addition, each will continue to participate in
Sherwin-Williams' employee welfare benefit plans and other benefit arrangements
for a period of four years following termination, and receive special retirement
benefits so that the total retirement benefits received will be equal to the
retirement benefits which would have been received had his employment with
Sherwin-Williams continued during the four year period following termination.
Each will also receive an additional payment equal to the amount of any excise
tax imposed on him by Section 4999 of the Internal Revenue Code and any taxes,
interest or penalties incurred with respect thereto. Assuming a termination date
of February 28, 2002, the lump sum cash amounts payable under the foregoing
provisions of the severance pay agreements (including any amount relating to the
excise tax described above) would have been approximately $10,202,695 and
$7,134,929 for Messrs. Connor and Scaminace, respectively.
For Messrs. Stellato, Morikis, Ivy and Pitorak, the severance pay
agreements provide that upon termination of employment for any reason (including
his right to terminate his employment for any reason during the thirty day
period immediately following the first anniversary date of a change of control)
other than death, disability, by Sherwin-Williams for cause or by the executive
for other than good reason, each will receive accrued salary, bonus and vacation
pay. Each executive will also receive a lump sum cash amount equal to three
times the sum of (a) twenty-six times his highest regular bi-weekly compensation
in effect within the three year period preceding termination, plus (b) the
greater of his highest bonus received within the three year period preceding
termination or the bonus he would have received for the year of termination had
he reached 100% of any stated goals (as explained in the Compensation and
Management Development Committee Report on Executive Compensation). In addition,
each will continue to participate in Sherwin-Williams' employee welfare benefit
plans and other benefit arrangements for a period of three years following
termination, and receive special retirement benefits so that the total
retirement benefits received will be equal to the retirement benefits which
would have been received had his employment with Sherwin-Williams continued
during the three year period following termination. Each will also receive an
additional payment equal to the amount of any excise tax imposed on him by
Section 4999 of the Internal Revenue Code and any taxes, interest or penalties
incurred with respect thereto. Assuming a termination date of
February 28, 2002, the lump sum cash amounts payable under the foregoing
provisions of the severance pay agreements (including any amount relating to the
excise tax described above) would have been approximately $1,710,719,
$2,745,410, $1,568,132 and $3,256,230 for Messrs. Stellato, Morikis, Ivy and
Pitorak, respectively.
The salary and other benefits provided by the severance pay agreements will
be payable either from an escrow fund established by Sherwin-Williams with a
national banking institution or from Sherwin-Williams' general funds.
Sherwin-Williams has agreed to indemnify each executive for any legal expense
incurred in the enforcement of his rights under the severance pay agreements.
MR. PITORAK'S AGREEMENT. Mr. Pitorak's service as an executive officer
ended in August 2001. In connection therewith, he entered into an agreement with
Sherwin-Williams, which provides that he will remain an employee until April 30,
2003 unless the agreement is earlier terminated. He will continue to receive
compensation at his last regular base salary rate, received a bonus in the
amount of $195,000 for 2001, and is entitled to receive a bonus for 2002 equal
to between 48% and 60% of his annual base salary in the event bonuses are paid
to the other named executive officers. The agreement provides that all unvested
stock
15
options will become exercisable in accordance with their terms, and all shares
of restricted stock previously granted will continue in accordance with their
terms. In the event he elects to retire under the agreement, all unvested
options will become fully vested. He will continue to be eligible to participate
in certain Sherwin-Williams retirement and employee benefit plans and programs
and will be entitled to receive such perquisites and fringe benefits to which he
was entitled while he was a named executive officer. In addition, he will
receive continued coverage under the Executive Life Insurance Plan until he
reaches age 62. His severance pay agreement will continue, provided that in the
event of a change of control of Sherwin-Williams, he will not be entitled to
duplicate benefits under such agreements. The agreement may be terminated for
cause by Sherwin-Williams, may be terminated by Mr. Pitorak voluntarily, and
will terminate in the event he commences regular, full-time employment.
APPROVAL OF THE SHERWIN-WILLIAMS COMPANY 2003 STOCK PLAN (PROPOSAL 2)
The Board of Directors has unanimously adopted and recommends The
Sherwin-Williams Company 2003 Stock Plan to the shareholders for approval. The
purpose of the 2003 Stock Plan is to attract and retain key executive,
managerial, technical and professional personnel by providing incentives and
rewards for performance. The Board of Directors believes the 2003 Stock Plan
will play an important role in management's efforts to attract and retain these
employees and help align the interests of employees and shareholders through
increased employee ownership of Sherwin-Williams. The Board of Directors
believes approval of the 2003 Stock Plan is in the best interests of
Sherwin-Williams and its shareholders.
The 2003 Stock Plan will replace The Sherwin-Williams Company 1994 Stock
Plan. The 1994 Stock Plan was originally approved by the shareholders at the
1993 Annual Meeting and is scheduled to expire on February 16, 2003. If approved
by the shareholders, the 2003 Stock Plan will go into effect on January 1, 2003,
and no further grants will be made under the 1994 Stock Plan as of that date.
The 2003 Stock Plan provides for awards to officers and other key employees
of stock options, stock appreciation rights (or "SARs") and restricted stock.
The 2003 Stock Plan does not permit the repricing of stock options or the grant
of discounted stock options. The 2003 Stock Plan is intended to satisfy the
requirements for performance-based compensation under Section 162(m) of the
Internal Revenue Code. On February 28, 2002, the closing price of
Sherwin-Williams common stock was $26.42 per share.
The material features of the 2003 Stock Plan are summarized below. The 2003
Stock Plan is attached to this Proxy Statement as Appendix A, and the following
summary is qualified in its entirety by reference to Appendix A.
ELIGIBILITY. Any officer or other key employee of Sherwin-Williams or any
of its subsidiaries may be selected by the Board of Directors to participate in
the 2003 Stock Plan. Participation is completely discretionary with the Board of
Directors. On February 28, 2002, the approximate number of persons eligible to
participate in the 2003 Stock Plan, including all of the executive officers, was
1,200.
NUMBER OF SHARES AVAILABLE. The number of shares of common stock which may
be awarded under the 2003 Stock Plan will not exceed 8,500,000 shares, plus the
shares authorized but not granted under the 1994 Stock Plan as of the expiration
thereof. No more than ten percent (10%) of these shares may be awarded as
restricted stock. On February 28, 2002, 3,497,860 shares remained available
under the 1994 Stock Plan. On February 28, 2002, 13,972,567 unexercised stock
options were outstanding under all Sherwin-Williams' stock option plans. Shares
awarded may be newly issued or treasury shares or a combination.
In addition, the following shares may also be awarded under the 2003 Stock
Plan: (a) shares awarded under the 2003 Stock Plan or the 1994 Stock Plan that
are forfeited or surrendered, (b) shares awarded under the 2003 Stock Plan or
the 1994 Stock Plan that expire or terminate without issuance of shares of
16
common stock, and (c) shares tendered by an employee to pay the exercise price
of a stock option granted under the 2003 Stock Plan or the 1994 Stock Plan, and
shares tendered by or withheld from an employee to satisfy withholding
obligations in respect of a stock option, an SAR or restricted stock awarded
under the 2003 Stock Plan or the 1994 Stock Plan.
STOCK OPTIONS. The Board of Directors may award stock options to eligible
employees. Stock options may be either non-qualified stock options or incentive
stock options intended to qualify under Section 422 of the Internal Revenue
Code. Each grant will specify the number of stock options granted and the
exercise price, which will be at least equal to the fair market value of common
stock on the date of grant. Stock options generally will be exercisable to the
extent of one-third of the shares granted on each of the first three anniversary
dates of the date of grant. In the event of the death of an employee, any stock
options outstanding will become immediately exercisable in full. The maximum
number of shares for which stock options may be granted to any eligible employee
during any calendar year is 1,000,000. Stock options are generally not
transferable except by will or the laws of descent and distribution. Generally,
all rights under any stock option will terminate on the earliest of the
following dates:
- the date on which the employee ceases to be an employee of
Sherwin-Williams except because of death or retirement,
- three years after the date of the death of the employee if the employee
dies while employed by Sherwin-Williams or dies following retirement,
- ten years from when the stock option was granted, and
- the date on which the employee intentionally commits an act materially
harmful to the interests of Sherwin-Williams.
SARS. The Board of Directors may award SARs to eligible employees with
respect to any stock options granted under any stock option plan or any
employment agreement. SARs may be exercised at any time when the related stock
option may be exercised by surrendering the unexercised stock option to Sherwin-
Williams. The amount due the employee at the time of exercise of the SAR may be
paid in shares of common stock, in cash or a combination. At the time of the
exercise of the SAR, the employee will be entitled to no more than the excess of
the fair market value of the shares of common stock covered by the related stock
option, as determined on the date such SAR is exercised, over the aggregate
stock option price provided for in the related stock option. The maximum number
of shares for which SARs may be granted to any eligible employee during any
calendar year is 1,000,000. The transferability of SARs is subject to the same
restrictions as stock options.
RESTRICTED STOCK. The Board of Directors may award restricted stock to
eligible employees. The grant of restricted stock constitutes an immediate
transfer of the ownership of shares of common stock to the employee and entitles
the employee to dividends, voting rights and other rights of ownership as the
Board of Directors may determine subject, however, to a substantial risk of
forfeiture and transfer restrictions. Each grant will specify the number of
shares of restricted stock granted and any consideration to be paid by the
employee to Sherwin-Williams. Each grant will be subject to a vesting
requirement, which will specify the percentage of shares of restricted stock
that the employee will be entitled to receive without restriction based upon
achievement of one or more performance goals. Performance goals will relate to
any of the following business criteria: earnings before interest, taxes,
depreciation and amortization; earnings per share; return on equity; return on
net assets employed; and free cash flow. A performance goal may be measured on a
periodic, annual, cumulative or average basis and may be established on a
corporate-wide basis or with respect to one or more operating units, divisions,
subsidiaries, acquired businesses, minority investments, partnerships or joint
ventures. The maximum number of shares of restricted stock that may be granted
to any eligible employee during any calendar year is 500,000.
ADMINISTRATION. The 2003 Stock Plan will be administered by the Board of
Directors, which may delegate all or any part of its authority to the
Compensation and Management Development Committee of the Board of Direc-
17
tors or another committee that is composed of two or more independent directors.
TERMINATION. The 2003 Stock Plan will terminate on April 23, 2012, unless
earlier terminated by the Board of Directors. Stock options, SARs and restricted
stock granted on or before that date will continue in force in accordance with
the terms of the award.
AMENDMENT. The 2003 Stock Plan may be amended by the Board of Directors,
provided, however, that after the 2003 Stock Plan has been approved by the
shareholders, no amendment shall be made without:
- the approval of the shareholders to the extent shareholder approval of
the amendment is required by applicable law or regulations or the
requirements of the principal exchange on which the common stock is
listed, if any, or to the extent the amendment increases the maximum
number of authorized shares (except for certain adjustments described
below) and
- the consent of each affected participant if the amendment would adversely
affect such participant's rights or obligations under any prior award.
The Board of Directors may amend any award document provided that, except
for certain adjustments described below, the stock option exercise price may not
be decreased following the date of grant, and no amendment shall, without the
consent of the participant, adversely effect or change any of the rights or
obligations under any prior award, except as otherwise set forth in the 2003
Stock Plan or an award document.
ADJUSTMENTS. The Board of Directors may adjust the exercise price, sale
price and the number or kind of shares of common stock or other securities
covered by stock options, SARs or restricted stock as it determines is equitably
required to prevent dilution or enlargement of rights resulting from any stock
split, stock dividend, combination of shares, recapitalization or other change
in the capital structure of Sherwin-Williams, any merger, consolidation,
separation, reorganization or partial or complete liquidation, or any other
corporate transaction or event having a similar effect. The Board of Directors
may also adjust the number or kind of shares of common stock or other securities
which may be sold or transferred under the 2003 Stock Plan and in the maximum
number of shares that may be purchased or received by any person, and may make
such other equitable adjustments, as the Board of Directors determines is
appropriate to reflect any of the foregoing events.
CHANGE OF CONTROL. In the event of a change of control of Sherwin-Williams
(as defined in the 2003 Stock Plan), any stock option or SARs outstanding shall,
notwithstanding any provisions providing for accrual in installments, become
immediately exercisable in full, and any shares of restricted stock outstanding
shall no longer be subject to any substantial risk of forfeiture, vesting
requirements or other restrictions.
PLAN BENEFITS. No stock options, SARs or restricted stock have been
granted under the 2003 Stock Plan. The Board of Directors has made no
determinations as to any awards under the 2003 Stock Plan, and, accordingly, the
amount of any benefits related to any awards cannot be determined. For
comparison purposes, the table below shows the awards that would have been made
in 2001 under the 2003 Stock Plan if it had been in effect. These awards are
identical to the awards actually made in 2001 under the 1994 Stock Plan.
18
NUMBER OF
NAME AND NUMBER OF SHARES OF VALUE OF
PRINCIPAL POSITION STOCK OPTIONS(1) RESTRICTED STOCK RESTRICTED STOCK($)(2)
------------------ ---------------- ---------------- ----------------------
C. M. Connor 250,000 50,000 1,301,500
Chairman and Chief Executive Officer
J. M. Scaminace 125,000 28,000 728,840
President and Chief Operating Officer
L. E. Stellato 30,000 7,000 182,210
Vice President, General Counsel
and Secretary
J. G. Morikis 60,000 13,000 338,390
President, Paint Stores Group
C. G. Ivy 30,000 7,000 182,210
Senior Vice President -- Corporate
Planning and Development
L. J. Pitorak -0- 13,000 338,390
Former Senior Vice
President -- Finance,
Treasurer and Chief Financial Officer
All Executive Officers as a Group 695,000 159,000 4,116,280
All Non-Executive Officer Directors as a -0- -0- -0-
Group
All Non-Executive Officer Employees as a 2,359,700 29,500 767,885
Group
---------------
(1) Stock options were granted under the 1994 Stock Plan at an exercise price
equal to the fair market value on the date of grant. Please refer to the
table on page 13 for potential realizable values.
(2) The value of restricted stock indicated is equal to the number of shares of
restricted stock granted multiplied by the closing price of common stock on
the date of grant.
FEDERAL INCOME TAX CONSEQUENCES
INCENTIVE STOCK OPTIONS. Under present federal income tax regulations,
generally there will be no federal income tax consequences to either
Sherwin-Williams or to a participant when an "incentive stock option" (ISO) is
granted or timely exercised. However, such consequences will arise when the
stock received under the stock option is sold or otherwise disposed. If the
participant retains the shares acquired through an ISO for the requisite holding
periods prescribed by the Internal Revenue Code, any gain or loss realized upon
a subsequent disposition will constitute long-term capital gain or loss to the
participant. The gain or loss is measured by the difference between the stock
option price and the proceeds of the sale. The requisite holding periods are two
years after the ISO is granted and one year after the shares subject to the ISO
are transferred to the participant. In general, if a participant disposes of the
shares prior to the expiration of the requisite holding periods, ordinary income
will be realized equal to the excess of the fair market value at the time of
exercise, over the stock option price. In certain circumstances, the amount of
ordinary income realized on a sale or exchange prior to the expiration of the
requisite holding periods is limited to the excess of the lesser of (a) the fair
market value at the time of exercise or (b) the amount realized upon such sale
or exchange, over the stock option price. Any gain in excess of such amount
realized on a subsequent sale or disposition would be taxed as a capital gain.
In general, if a disposition occurs prior to the expiration of the holding
period, Sherwin-Williams will be entitled to a deduction equal to the ordinary
income realized by the participant.
Although a participant will not realize ordinary income upon the exercise
of an ISO, the excess of the fair market value of the shares acquired at the
time of exercise over the stock option price is included as an adjustment in
computing "alternative minimum taxable
19
income" under Section 56 of the Internal Revenue Code, and thus, may result in
the imposition of the "alternative minimum tax" for the participant pursuant to
Section 55 of the Internal Revenue Code.
NON-QUALIFIED STOCK OPTIONS. Under present federal income tax regulations,
generally the granting of a "non-qualified" stock option will not result in
federal income tax consequences to either Sherwin-Williams or the participant.
However, upon exercise of such stock option, the participant will realize
ordinary income measured by the excess of the then fair market value of the
shares acquired upon exercise of the non-qualified stock option, over the stock
option price. Sherwin-Williams will be entitled to a deduction for a
corresponding amount if and to the extent that the amount is an ordinary and
necessary expense, is not limited by Section 162(m) of the Internal Revenue
Code, and satisfies the test of reasonable compensation. If the participant
retains the shares for the requisite holding period prescribed by the Internal
Revenue Code, the gain or loss upon a subsequent sale or exchange will
constitute a long-term capital gain or loss. For purposes of determining gain or
loss realized upon a subsequent sale or exchange of such shares, the
participant's tax basis will be the sum of the stock option price paid and the
amount of ordinary income, if any, recognized by the participant on the date of
exercise.
RESTRICTED STOCK. During the period that shares of restricted stock are
subject to a "substantial risk of forfeiture," no taxable income will be
recognized by a participant with respect thereto except with respect to
dividends paid thereon. However, the participant has the right to elect under
Section 83 of the Internal Revenue Code, within a thirty day period from the
date of transfer, to include in his taxable income for that year an amount equal
to the excess of the fair market value of such shares (determined without regard
to the restrictions) at the time of transfer to him, over the amount, if any,
paid for such shares. In general, if the participant does not make this election
timely, he will realize ordinary taxable income for the year in which the
restrictions terminate or otherwise cease to impose a substantial risk of
forfeiture in an amount equal to the excess of the fair market value of the
shares held by him on the day the restrictions expire or are removed over the
amount, if any, paid for such shares, and Sherwin-Williams ordinarily will be
entitled to a corresponding deduction.
SARS. Under present federal income tax regulations, there will be no
federal income tax consequences to either Sherwin-Williams or the participant
upon the grant of SARs. Upon exercise of an SAR by a participant, the amount of
any cash received and the fair market value of any shares of common stock
received will be taxable to the participant as ordinary income, and
Sherwin-Williams ordinarily will be entitled to a corresponding deduction. The
tax basis of any common stock received will be its fair market value on the
exercise date.
WITHHOLDING TAXES. Sherwin-Williams will have the right to deduct from any
transfer of shares or other payment an amount equal to the income and employment
taxes required to be withheld by it with respect to such transfer and payment
and to require the participant or other person receiving such transfer or
payment to pay to Sherwin-Williams any additional amount of such taxes.
Notwithstanding the foregoing, when the participant is required to pay to
Sherwin-Williams such withholding taxes, the participant may satisfy the
obligation by electing to have withheld, from the shares required to be
delivered, shares of common stock having a value equal to the amount required to
be withheld (except in the case of restricted stock where an election under
Section 83(b) of the Internal Revenue Code has been made) or by delivering to
Sherwin-Williams other shares of common stock. The shares used for tax
withholding settlement will be valued at the fair market value of common stock
on the day the tax is first determinable. An election by a participant to have
shares withheld or to deliver other shares of common stock for this purpose must
be made prior to the day the tax is first determinable and will be subject to
the disapproval of the Board of Directors.
THE BOARD OF DIRECTORS RECOMMENDS THAT YOU VOTE "FOR" THE APPROVAL OF THE
2003 STOCK PLAN.
20
SECURITY OWNERSHIP OF MANAGEMENT
The following table sets forth, as to each director and nominee, each
executive officer named in the Summary Compensation Table and all directors and
executive officers as a group, information regarding the amount and nature of
shares of common stock beneficially owned and the amount of shadow stock units
owned at December 31, 2001. All of the directors and executive officers have
sole voting and investment power over the shares of common stock listed or share
voting and investment power with his or her spouse, except as otherwise provided
below. No director or executive officer beneficially owns any shares of serial
preferred stock.
AMOUNT AND NATURE
OF COMMON STOCK PERCENT OF AMOUNT OF
BENEFICIALLY COMMON STOCK SHADOW STOCK
NAME OF BENEFICIAL OWNER OWNED(1,2,3) BENEFICIALLY OWNED OWNED(4)
------------------------ ----------------- ------------------ ------------
J. C. Boland 6,999 * 6,541
J. G. Breen 957,282 * -0-
D. E. Collins 15,999 * 10,746
C. M. Connor 605,984 * 28,353
D. E. Evans 11,899 * -0-
C. G. Ivy 312,948 * 18,881
R. W. Mahoney 12,999 * -0-
G. E. McCullough(5) 250 * -0-
A. M. Mixon, III 17,999 * 16,296
C. E. Moll(6) 18,323 * -0-
J. G. Morikis 136,844 * 5,884
L. J. Pitorak 259,068 * 25,276
J. M. Scaminace 466,465 * 30,599
R. K. Smucker 17,945 * -0-
L. E. Stellato 141,444 * 22,316
All directors and executive 3,580,495 2.29 212,608
officers as a group
---------------
*Represents beneficial ownership of less than 1% of the total number of shares
of common stock outstanding.
(1) The amounts listed include shares of common stock held under plans offered
by Sherwin-Williams for which the directors and executive officers have the
right to direct the vote, including the following approximate number of
shares included in units held under the Employee Stock Purchase and Savings
Plan: Mr. Connor, 36,402; Mr. Ivy, 139,544; Mr. Morikis, 10,511; Mr.
Pitorak, 16,752; Mr. Scaminace, 25,623; Mr. Stellato, 21,218; and all
executive officers as a group, 319,503.
(2) The amounts listed include the following number of shares of common stock
owned by immediate family members of the directors and executive officers,
for which each such person disclaims beneficial ownership: Mr. Ivy, 21,038;
Mr. Moll, 540; and all directors and executive officers as a group, 21,578.
(3) The amounts listed include the following number of shares of common stock
for which the directors and executive officers have the right to acquire
beneficial ownership, within sixty days from December 31, 2001, through the
exercise of stock options: Mr. Boland, 5,999; Mr. Breen, 666,666; Mr.
Collins, 7,999; Mr. Connor, 459,666; Mr. Evans, 7,333; Mr. Ivy, 137,200; Mr.
Mahoney, 7,999; Mr. Mixon, 7,999; Mr. Moll, 7,999; Mr. Morikis, 102,333; Mr.
Pitorak, 213,667; Mr. Scaminace, 377,668; Mr. Smucker, 7,999; Mr. Stellato,
106,000; and all directors and executive officers as a group, 2,564,325.
21
(4) The amounts listed include the number of shares of shadow stock owned by
nonemployee directors under the Director Deferred Fee Plan, whereby
nonemployee directors may defer payment of all or a portion of their
directors' fees into a shadow stock account. The amounts listed also include
the approximate number of shares of shadow stock included in shadow stock
units owned by executive officers under the Deferred Compensation Savings
Plan and Key Management Deferred Compensation Savings Plan, whereby eligible
employees may defer payment of a portion of such employee's compensation
into a shadow stock account. The value of shares of shadow stock and shadow
stock units fluctuates according to the market value of common stock,
including reinvestment of dividends. Directors and executive officers have
no voting rights associated with shadow stock or shadow stock units, and
such ownership does not result in any beneficial ownership of common stock.
(5) Information for Mr. McCullough is as of February 6, 2002, the date he was
appointed a director.
(6) Includes 2,000 shares owned by the MTD Products, Inc. pension fund, of which
Mr. Moll is a trustee.
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS
The following table sets forth, as to each beneficial owner of more than
five percent of each class of voting securities, information regarding shares
owned by each at December 31, 2001.
COMMON STOCK
AMOUNT AND NATURE OF PERCENT OF
NAME OF BENEFICIAL OWNER BENEFICIAL OWNERSHIP CLASS
------------------------ -------------------- ----------
AXA Financial, Inc.(1) 13,527,280(1) 8.79%
1290 Avenue of the Americas
New York, New York 10104
Barclays Global Investors, N.A.(2) 9,376,457(2) 6.09%
45 Fremont Street
San Francisco, California 94105
Brandes Investment Partners, L.P.(3) 14,369,798(3) 9.33%
11988 El Camino Real, Suite 500
San Diego, California 92130
The Sherwin-Williams Company
Employee Stock Purchase
and Savings Plan 23,140,191(4) 15.03%
101 Prospect Avenue, N.W.
Cleveland, Ohio 44115
SERIAL PREFERRED STOCK
AMOUNT AND NATURE OF PERCENT OF
NAME OF BENEFICIAL OWNER BENEFICIAL OWNERSHIP CLASS
------------------------ -------------------- ----------
The Sherwin-Williams Company
Employee Stock Purchase
and Savings Plan 168,305(5) 100%
101 Prospect Avenue, N.W.
Cleveland, Ohio 44115
---------------
(1) Based on a Schedule 13G filed February 12, 2002, AXA Financial, Inc. and
certain of its affiliated entities (collectively, "AXA") beneficially owned
13,527,280 shares of common stock at December 31, 2001. Of such shares,
Alliance Capital Management L.P. owned 12,028,380 shares, AXA Rosenberg
Investment Management LLC owned 1,438,400 shares, AXA Konzern AG (Germany)
22
owned 59,400 shares, and The Equitable Life Assurance Society of the United
States owned 1,100 shares. Of the total shares, AXA had sole voting power
over 6,524,490 shares, shared voting power over 1,233,199 shares, sole
dispositive power over 12,088,880 shares and shared dispositive power over
1,438,400 shares.
(2) Based on a Schedule 13G filed February 14, 2002, Barclays Global Investors,
N.A. and certain of its affiliated entities (collectively, "Barclays")
beneficially owned 9,376,457 shares of common stock at December 31, 2001. Of
such shares, Barclays Global Investors owned 7,808,040 shares, Barclays
Global Fund Advisors owned 804,025 shares, Barclays Global Investors, LTD.
owned 665,642 shares, Barclays Funds Limited owned 29,183 shares, Barclays
Trust and Banking Company (Japan) Ltd. owned 55,667 shares, Barclays Life
Assurance Company Ltd. owned 13,100 shares, and Barclays Capital Securities,
Ltd. owned 800 shares. Of the total shares, Barclays had sole voting power
over 8,775,829 shares, shared voting power over none of the shares, sole
dispositive power over all of the shares and shared dispositive power over
none of the shares.
(3) Based on a Schedule 13G filed February 14, 2002, Brandes Investment
Partners, L.P. beneficially owned 14,369,798 shares of common stock at
December 31, 2001. Brandes Investment Partners, Inc., Brandes Holdings,
L.P., Charles H. Brandes, Glenn R. Carlson and Jeffrey A. Busby are deemed
to beneficially own all of the shares as control persons. Of the total
shares, Brandes had sole voting power over none of the shares, shared voting
power over 10,055,378 shares, sole dispositive power over none of the shares
and shared dispositive power over all of the shares.
(4) Shares of common stock owned pursuant to the Employee Stock Purchase and
Savings Plan are voted by the trustee in accordance with written
instructions of plan participants. If no instructions are received by the
trustee, the trustee votes such shares (along with any unallocated shares
held in the plan) in the same proportion as it votes those shares for which
it receives proper instructions.
(5) Shares of convertible participating serial preferred stock are held in an
unallocated suspense account in the Employee Stock Purchase and Savings
Plan. Shares are voted by the trustee in the same proportion as unallocated
shares of common stock are voted, as described above.
23
SECTION 16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE
Section 16(a) of the Securities Exchange Act of 1934 requires
Sherwin-Williams directors and executive officers to file reports of ownership
and changes in ownership of Sherwin-Williams' equity securities with the
Securities and Exchange Commission and the New York Stock Exchange. To
Sherwin-Williams' knowledge, based solely on information furnished to
Sherwin-Williams and written representations by such persons, all of the
directors and executive officers complied with their filing requirements in
2001, except that (a) Mr. Breen inadvertently filed a Form 4 late reporting one
transaction for a sale of common stock and (b) Mr. Scaminace inadvertently filed
a Form 4 late reporting two transactions relating to the exercise of stock
options. Upon discovery, Mr. Breen and Mr. Scaminace promptly filed Forms 4
reporting the transactions.
CERTAIN RELATIONSHIPS AND
RELATED TRANSACTIONS
During 2001, Sherwin-Williams paid to Accuspray, Inc. $246,517 for products
purchased by Sherwin-Williams. Mr. Mixon, a director of Sherwin-Williams, is a
minority shareholder of Accuspray. Sherwin-Williams expects to make purchases
from Accuspray in 2002.
Please also refer to the description of Mr. Breen's consulting arrangement
set forth under the caption entitled "Compensation of Directors" on page five.
EXPENSE AND METHOD OF PROXY SOLICITATION
The enclosed proxy is solicited by the Board of Directors and the entire
cost of solicitation will be paid by Sherwin-Williams. In addition to the
solicitation of proxies by use of the mail, officers and other Sherwin-Williams
employees may solicit the return of proxies. Georgeson Shareholder
Communications Inc. has also been retained to aid in the solicitation of
proxies, for which it will receive a fee estimated at $15,000 plus reasonable
expenses. Proxies will be solicited by personal interview, mail, telephone and
electronic means.
SHAREHOLDER PROPOSALS FOR
2003 ANNUAL MEETING
Shareholder proposals must be received at Sherwin-Williams' headquarters,
101 Prospect Avenue, N.W., Cleveland, Ohio 44115-1075, Attention: Vice
President, General Counsel and Secretary, on or before November 12, 2002 in
order to be considered for inclusion in the proxy materials relating to the 2003
Annual Meeting of Shareholders. In addition, if Sherwin-Williams is not provided
with written notice of a shareholder proposal on or before January 26, 2003,
proxies solicited by the Board of Directors for the 2003 Annual Meeting of
Shareholders will confer discretionary authority to vote on the shareholder
proposal if presented at such Annual Meeting. In order to remove any question as
to the date on which a proposal was received, it is suggested that proposals be
submitted by certified mail-return receipt requested.
HOUSEHOLDING INFORMATION
Some banks, brokers and other nominees are participating in the practice of
"householding" proxy statements and annual reports. This means that beneficial
holders of Sherwin-Williams common stock who share the same address or household
may not receive separate copies of this Proxy Statement and our 2001 Annual
Report. We will promptly deliver an additional copy of either document to you if
you write or call us at the following address or phone number: 101 Prospect
Avenue, N.W., Cleveland, Ohio 44115-1075, Attention: Investor Relations, (216)
566-2000.
ANNUAL REPORT ON FORM 10-K
WE WILL PROVIDE TO EACH SHAREHOLDER WHO IS SOLICITED TO VOTE AT THE 2002
ANNUAL MEETING OF SHAREHOLDERS, UPON THE WRITTEN REQUEST OF SUCH PERSON AND
WITHOUT CHARGE, A COPY OF OUR 2001 ANNUAL REPORT ON FORM 10-K. PLEASE WRITE TO
US AT 101 PROSPECT AVENUE, N.W., CLEVELAND, OHIO 44115-1075, ATTENTION: INVESTOR
RELATIONS.
24
APPENDIX A
THE SHERWIN-WILLIAMS COMPANY
2003 STOCK PLAN
The Sherwin-Williams Company 2003 Stock Plan is established effective as of
January 1, 2003. The purpose of the Plan is to attract and retain key executive,
managerial, technical and professional personnel for The Sherwin-Williams
Company and its Subsidiaries by providing incentives and rewards for performance
by such personnel.
ARTICLE I
DEFINITIONS
As used herein, the following terms shall have the following respective
meanings unless the context clearly indicates otherwise:
1.01 1994 Stock Plan. The Sherwin-Williams Company 1994 Stock Plan.
1.02 Appreciation Right. A right to receive from the Company, upon
surrender of the related stock option, an amount equal to the Spread in
accordance with Article IV.
1.03 Award. An Option Right, Appreciation Right, grant or sale of
Restricted Stock, or any combination of the foregoing.
1.04 Award Document. An agreement, certificate, notice or other type or
form of document or documentation which sets forth the terms and conditions of
an Award. An Award Document may be in written, electronic or other media, may be
limited to a notation on the books and records of the Company and need not be
signed by a representative of the Company or a Participant.
1.05 Board of Directors. The Board of Directors of the Company.
1.06 Code. The Internal Revenue Code of 1986, as the same has been or may
be amended from time-to-time.
1.07 Committee. The Compensation and Management Development Committee of
the Board of Directors or such other committee designated by the Board of
Directors to administer the Plan that is composed of two (2) or more independent
directors appointed by the Board of Directors.
1.08 Common Stock. Common stock, par value $1.00 per share, of the
Company or any security into which such common stock may be changed by reason of
any transaction or event of the type described in Article VIII.
1.09 Company. The Sherwin-Williams Company, or its corporate successor or
successors.
1.10 Date of Grant. The date specified by the Board of Directors on which
a grant or sale of an Award shall become effective.
1.11 Eligible Employees. Persons who are selected by the Board of
Directors and who are, at the time such persons are selected, officers
(including officers who are members of the Board of Directors) or other key
employees of the Company or any of its Subsidiaries.
1.12 Fair Market Value. The average between the highest and the lowest
quoted selling price of Common Stock on the New York Stock Exchange or any
successor exchange.
1.13 ISO. An "incentive stock option" within the meaning of Section 422
of the Code.
1.14 Option Right. The right to purchase a share of Common Stock upon
exercise of an option granted pursuant to Article III.
A-1
1.15 Participant. An Eligible Employee named in an Award Document
evidencing an outstanding Award.
1.16 Performance Period. A period of time designated by the Board of
Directors over which one or more Performance Goals may be measured.
1.17 Performance Goal. Any of the following business criteria: earnings
before interest, taxes, depreciation and amortization; earnings per share;
return on equity; return on net assets employed; and free cash flow. A
Performance Goal may be measured over a Performance Period on a periodic,
annual, cumulative or average basis and may be established on a corporate-wide
basis or established with respect to one or more operating units, divisions,
Subsidiaries, acquired businesses, minority investments, partnerships or joint
ventures.
1.18 Plan. The Sherwin-Williams Company 2003 Stock Plan, as amended from
time-to-time.
1.19 Restricted Stock. Shares of Common Stock granted or sold pursuant to
Article V as to which neither the substantial risk of forfeiture nor the
prohibition or restriction on transfer has lapsed, terminated or been cancelled.
1.20 Retirement. Retirement under a retirement plan of the Company or a
Subsidiary at or after attaining the age of fifty-five (55) with ten (10) or
more years of service or retirement at an earlier age with the consent of the
Board of Directors.
1.21 Spread. The excess of the Fair Market Value per share of Common
Stock on the date when an Appreciation Right is exercised over the option price
provided for in the related stock option.
1.22 Subsidiary. Any corporation (other than the Company) in an unbroken
chain of corporations beginning with the Company if, at the time of the granting
or sale of the Award each of the corporations other than the last corporation in
the unbroken chain owns stock possessing fifty percent or more of the total
combined voting power of all classes of stock in one of the other corporations
in such chain.
1.23 Tax Date. The date upon which the tax is first determinable.
ARTICLE II
COMMON STOCK AVAILABLE
2.01 Number of Shares. The shares of Common Stock (a) sold upon the
exercise of Option Rights, (b) delivered upon the exercise of Appreciation
Rights or (c) awarded or sold as Restricted Stock and released from any
substantial risk of forfeiture shall not exceed in the aggregate 8,500,000
shares plus the number of shares of Common Stock authorized pursuant to the 1994
Stock Plan which are not granted pursuant to the 1994 Stock Plan as of the
expiration thereof, and of which not more than ten percent (10%) of such total
authorized shares shall be available to be awarded or sold as Restricted Stock
and released from any substantial risk of forfeiture, all subject to adjustment
as provided in Articles VII and VIII. Such shares may be shares of original
issuance or treasury shares or a combination of the foregoing.
2.02 Reuse of Shares. In addition to the shares authorized in Section
2.01, the following shares also may again be used for future Awards under the
Plan: (a) shares awarded under the Plan or the 1994 Stock Plan that are
subsequently forfeited or surrendered in accordance with the Plan or the 1994
Stock Plan, (b) shares awarded under the Plan or the 1994 Stock Plan that
subsequently expire or terminate for any reason without issuance of shares of
Common Stock, and (c) shares tendered by a Participant in payment of all or part
of the exercise price of an Option Right granted under the Plan or the 1994
Stock Plan, and shares tendered by or withheld from a Participant in
satisfaction of the withholding obligations in respect of an Option Right, an
Appreciation Right or Restricted Stock granted under the Plan or the 1994 Stock
Plan.
A-2
ARTICLE III
OPTION RIGHTS
3.01 Authorization and Terms. The Board of Directors may from
time-to-time authorize the granting of Option Rights to Eligible Employees to
purchase shares of Common Stock. Each grant shall be subject to the following
terms, conditions and limitations and such other terms, conditions and
limitations not inconsistent with the Plan as may be set forth in the applicable
Award Document:
(A) Each grant shall specify the number of shares of Common Stock to
which it pertains.
(B) Each grant shall specify an option price per share equal to at
least the Fair Market Value per share on the Date of Grant, and that such
option price shall be payable in full at the time of exercise of the Option
Right either (i) in cash, (ii) by exchanging for the shares to be issued
pursuant to the exercise of the Option Right previously acquired shares of
Common Stock held for such period of time, if any, as the Board of
Directors may require (valued at an amount equal to the Fair Market Value
on the date of exercise), (iii) by delivering a properly executed exercise
notice to the Company together with irrevocable instructions to a broker to
deliver promptly to the Company the amount of sale or loan proceeds with
respect to the shares to be acquired upon exercise having a Fair Market
Value on the date of exercise equal to the exercise price, or (iv) a
combination of the payment methods specified in clauses (i), (ii) and
(iii). The proceeds of sale of Common Stock subject to Option Rights are to
be added to the general funds of the Company or to the shares of the Common
Stock held in treasury and used by the Company for general corporate
purposes.
(C) Successive grants may be made to the same Eligible Employee
whether or not any Option Rights previously granted to such Eligible
Employee remain unexercised.
(D) The Option Rights may be either (i) options which are intended to
qualify under particular provisions of the Code, including, but not limited
to, ISOs, (ii) options which are not intended to so qualify or (iii) any
combination of separate grants of both (i) and (ii).
(E) Unless otherwise set forth in the applicable Award Document, an
Option Right (until terminated as provided herein) shall be exercisable to
the extent of one-third of the shares granted one full year from the Date
of Grant and to the extent of an additional one-third of such shares on the
date two years and the date three years from the Date of Grant. Unless
otherwise set forth in the applicable Award Document, in the event of the
death of the Participant, any Option Rights outstanding shall,
notwithstanding the provision providing for accrual in installments set
forth in the preceding sentence, become immediately exercisable in full. To
the extent exercisable, the Option Rights may be exercised in whole or in
part from time-to-time.
(F) Except as otherwise set forth in the applicable Award Document,
all rights under any Option Right, including any Option Right installment
which has not previously become exercisable, shall cease and terminate on
the earliest of the following dates:
(i) The date on which a Participant ceases to be an employee of the
Company or a Subsidiary for any reason whatsoever unless the Participant
ceases to be such employee by reason of (a) death or (b) Retirement;
(ii) Three years after the date of the death of the Participant if
(a) the Participant dies while an employee of the Company or a
Subsidiary or (b) the Participant dies following his or her Retirement;
(iii) Ten years from the date on which the Option Right was
granted; and
(iv) The date on which the Participant intentionally commits an act
materially harmful to the interests of the Company or a Subsidiary as
determined by the Board of Directors.
A-3
(G) Nothing contained in the Plan shall limit whatever right the
Company or a Subsidiary might otherwise have to terminate the employment of
the Participant, and the terms of an Option Right shall not be affected in
any manner by any employment or other agreement between the Participant and
the Company or any Subsidiary.
(H) An Option Right shall not be exercisable if such exercise would
involve a violation of any applicable federal or state securities law. An
Option Right shall not be exercisable if at the time of exercise such
exercise would require registration under the Securities Act of 1933, as
amended, or under any similar federal securities law then in effect, of the
shares of Common Stock or other securities to be purchased thereunder, and
such registration shall not then be effective. The Company shall register
the shares of Common Stock or other securities covered by an Option Right
under any such law if (i) such registration shall be necessary for the
exercise of an Option Right and the Board of Directors shall not determine
that such registration would result in undue expense or undue hardship to
the Company or (ii) the Board of Directors, in it sole discretion, shall
determine that such registration is desirable to effect the purposes for
which the Option Right is granted and would not result in undue expense or
undue hardship to the Company.
(I) Each grant of Option Rights shall be evidenced by an Award
Document issued on behalf of the Company and delivered to the Participant.
(J) The number of shares for which Option Rights may be granted to any
Eligible Employee during any calendar year shall not exceed 1,000,000.
ARTICLE IV
APPRECIATION RIGHTS
4.01 Authorization and Terms. The Board of Directors may from
time-to-time authorize the granting of Appreciation Rights to Eligible Employees
in respect of any or all stock options heretofore or hereafter granted
(including stock options simultaneously granted) pursuant to any stock option
plan or employment agreement of the Company now or hereafter in effect, whether
or not such stock options are at such time exercisable, to the extent that such
stock options at such time have not been exercised and have not been terminated.
Each grant shall be subject to the terms, conditions and limitations set forth
herein and such other terms, conditions and limitations not inconsistent with
the Plan as may be set forth in the applicable Award Document. The amount which
may be due the Participant at the time of the exercise of an Appreciation Right
may be paid by the Company in whole shares of Common Stock (valued at an amount
equal to the Fair Market Value on the date of exercise), in cash or a
combination thereof, as the Board of Directors shall determine. Each grant of
Appreciation Rights shall be evidenced by an Award Document issued on behalf of
the Company and delivered to the Participant.
4.02 Exercise of Appreciation Rights. An Appreciation Right may be
exercised at any time when the related stock option may be exercised by the
surrender to the Company, unexercised, of the related stock option.
4.03 Limitation on Payments. The amount payable on the exercise of any
Appreciation Rights may not exceed 100% (or such lesser percentage as the Board
of Directors may determine) of the aggregate Spread of the shares of Common
Stock covered by the related stock option.
4.04 Termination of Appreciation Rights. An Appreciation Right shall
terminate and may no longer be exercised upon the earlier of (a) exercise or
termination of the related stock option or (b) any termination date set forth in
the applicable Award Document.
4.05 Limitation on Number of Appreciation Rights. The number of shares for
which Appreciation Rights may be granted to any Eligible Employee during any
calendar year shall not exceed 1,000,000.
A-4
ARTICLE V
RESTRICTED STOCK
5.01 Authorization and Terms. The Board of Directors may from
time-to-time authorize the granting or sale of Restricted Stock to Eligible
Employees. Each grant or sale shall be subject to the following terms,
conditions and limitations and such other terms, conditions and limitations not
inconsistent with the Plan as may be set forth in the applicable Award Document:
(A) Each grant or sale shall constitute an immediate transfer of the
ownership of shares of Common Stock to the Participant in consideration of
the performance of services and shall entitle such Participant to voting,
dividend and other ownership rights, as the Board of Directors may
determine, subject, however, to a "substantial risk of forfeiture," within
the meaning of Section 83 of the Code and the regulations thereunder, and
restrictions on transfer as the Board of Directors may determine.
(B) Each grant or sale may be made without additional consideration or
in consideration of a payment by such Participant that is less than the
Fair Market Value per share on the Date of Grant.
(C) Each grant or sale of Restricted Stock shall be evidenced by an
Award Document issued on behalf of the Company and delivered to the
Participant.
(D) Each grant or sale shall be subject to a vesting requirement as
specified by the Board of Directors. The vesting requirement shall specify
the percentage of the number of shares of Restricted Stock granted to any
Participant that such Participant shall be entitled to receive without
restriction based upon achievement of one or more Performance Goals.
(E) The number of shares of Restricted Stock that may be granted to
any Eligible Employee during any calendar year shall not exceed 500,000.
ARTICLE VI
ADMINISTRATION OF THE PLAN
6.01 Generally. The Plan shall be administered by the Board of Directors,
which may from time-to-time delegate all or any part of its authority under the
Plan to a Committee.
6.02 Interpretation and Construction. The interpretation and construction
by the Board of Directors of any provision of the Plan or of any Award Document
and any determination by the Board of Directors, in its business judgement,
pursuant to any provision of the Plan or of any such Award Document shall be
final and conclusive. No member of the Board of Directors shall be liable for
any such action or determination. All questions pertaining to the construction,
interpretation, regulation, validity and effect of the terms and provisions of
the Plan shall be determined in accordance with the laws of the State of Ohio.
ARTICLE VII
AMENDMENT AND TERMINATION
7.01 Amendment of the Plan. The Plan may be amended from time-to-time by
the Board of Directors; provided, however, that after the Plan has been approved
by the shareholders of the Company, no amendment of the Plan shall be made by
the Board of Directors without (a) the approval of the Company's shareholders to
the extent shareholder approval of the amendment is required by applicable law
or regulations or the requirements of the principal exchange on which the Common
Stock is listed, if any, or to the extent the amendment increases the maximum
number of shares specified in Article II (except that adjustments authorized by
Section 8.02 shall not be limited by this provision) and (b) the consent of each
affected Participant if such amendment would
A-5
adversely affect such Participant's rights or obligations under any Award made
prior to the date of such amendment.
7.02 Amendment of Award Documents. The Board of Directors may amend any
Award Document evidencing an Award, provided, however, that except as provided
in Section 8.02, (a) the option price per share may not be decreased following
the Date of Grant of any related Option Right and (b) no such amendment shall,
without the consent of the Participant, adversely affect such Participant's
rights or obligations under any Award made prior to the date of such amendment,
except as otherwise set forth in the Plan or the applicable Award Document.
7.03 Automatic Termination. Unless earlier terminated by the Board of
Directors, the Plan will terminate at midnight on April 23, 2012, and no new
Awards may be granted thereafter. However, Awards previously granted will
continue in force beyond such date subject to the terms and provisions of the
Plan and the applicable Award Document.
ARTICLE VIII
MISCELLANEOUS
8.01 Transferability. Unless otherwise set forth in the applicable Award
Document, no Option Right or Appreciation Right shall be transferable by a
Participant other than by will or the laws of descent and distribution, and
Option Rights and Appreciation Rights shall be exercisable during the
Participant's lifetime only by the Participant. No right or interest of any
Participant in any Award shall be subject to alienation, anticipation,
encumbrance, garnishment, attachment, any lien, obligation or liability of such
Participant, or execution or levy of any kind, voluntary or involuntary, except
as provided herein or required by law.
8.02 Adjustments. The Board of Directors may make or provide for such
adjustments in the exercise price, sale price and the number or kind of shares
of Common Stock or other securities covered by outstanding Awards as the Board
of Directors in its sole discretion, as determined in its business judgement,
may determine is equitably required to prevent dilution or enlargement of the
rights of Participants that would otherwise result from (a) any stock dividend,
stock split, combination of shares, recapitalization or other change in the
capital structure of the Company, (b) any merger, consolidation, separation,
reorganization or partial or complete liquidation, or (c) any other corporate
transaction or event which in the determination of the Board of Directors, as
determined in its business judgement, has an effect similar to any of the
foregoing. The Board of Directors may also make or provide for such adjustments
in the number or kind or shares of the Company's Common Stock or other
securities which may be sold or transferred under the Plan and in the maximum
number of shares that may be purchased or received by any person, and may make
such other equitable adjustments, as the Board of Directors in its sole
discretion, as determined in its business judgement, may determine is
appropriate to reflect any event of the type described in clauses (a), (b)
and/or (c) of the preceding sentence.
8.03 Fractional Shares. The Company shall not be required to sell or
transfer any fractional share of Common Stock pursuant to the Plan. The Board of
Directors may provide for the elimination of fractions or for the settlement of
fractions in cash.
8.04 Withholding Taxes. The Company shall have the right to deduct from
any transfer of shares or other payment under the Plan an amount equal to the
federal, state and local income taxes and employment taxes required to be
withheld by it with respect to such transfer and payment and, if the cash
portion of any such payment is less than the amount of taxes required to be
withheld, to require the Participant or other person receiving such transfer or
payment, to pay to the Company the balance of such taxes so required to be
withheld. Notwithstanding the foregoing, when a Participant is required to pay
to the Company an amount required to be withheld under applicable income and
employment tax laws, the Participant, in accordance with such rules as may be
specified by the Board of Directors, may elect to satisfy the obligation, in
whole or in part, by electing to have
A-6
withheld, from the shares required to be delivered to the Participant, shares of
Common Stock having a value equal to the amount required to be withheld (except
in the case of Restricted Stock where an election under Section 83(b) of the
Code has been made), or by delivering to the Company other shares of Common
Stock held by such Participant. The shares used for tax withholding settlement
will be valued at an amount equal to the Fair Market Value of such Common Stock
on the Tax Date. Election by a Participant to have shares withheld or to deliver
other shares of Common Stock for this purpose will be subject to the following
restrictions: (a) such election must be made prior to the Tax Date and (b) such
election will be subject to the disapproval of the Board of Directors. In no
event shall the aggregate Fair Market Value of the shares of Common Stock
withheld and/or delivered pursuant to this Section 8.04 to satisfy applicable
withholding taxes in connection with an Award exceed the minimum amount of taxes
required to be withheld.
8.05 Change of Control. Unless otherwise set forth in the applicable
Award Document, in the event of a "Change of Control" of the Company, as defined
below, (a) any Option Rights or Appreciation Rights outstanding shall,
notwithstanding any provisions providing for accrual in installments, become
immediately exercisable in full and (b) any Restricted Stock Awards outstanding
shall no longer be subject to any substantial risk of forfeiture, restrictions
on transfer or vesting requirements. A "Change of Control" shall be deemed to
have occurred if:
(A) Any person (as such term is used in Sections 13(d) and 14(d)(2) of
the Securities Exchange Act of 1934, as amended, hereinafter the "Exchange
Act") who or that, together with all "Affiliates" and "Associates" (as such
terms are defined in Rule 12b-2, as in effect on April 23, 1997, of the
General Rules and Regulations under the Exchange Act) of such person, is
the Beneficial Owner (as defined below) of ten percent (10%) or more of the
shares of Common Stock then outstanding, except:
(i) the Company;
(ii) any of the Company's subsidiaries in which a majority of the
voting power of the equity securities or equity interests of such
subsidiary is owned, directly or indirectly, by the Company;
(iii) any employee benefit or stock ownership plan of the Company
or any trustee or fiduciary with respect to such a plan acting in such
capacity; or
(iv) any such person who has reported or may, pursuant to Rule
13d-1(b)(1) of the General Rules and Regulations under the Exchange Act,
report such ownership (but only as long as such person is the Beneficial
Owner of less than fifteen percent (15%) of the shares of Common Stock
then outstanding) on Schedule 13G (or any comparable or successor
report) under the Exchange Act.
Notwithstanding the foregoing: (a) no person shall become the Beneficial
Owner of ten percent (10%) or more (fifteen percent (15%) or more in the
case of any person identified in clause (iv) above) solely as the result of
an acquisition of Common Stock by the Company that, by reducing the number
of shares outstanding, increases the proportionate number of shares
beneficially owned by such person to ten percent (10%) or more (fifteen
percent (15%) or more in the case of any person identified in clause (iv)
above) of the shares of Common Stock then outstanding; provided, however,
that if a person becomes the Beneficial Owner of ten percent (10%) or more
(fifteen percent (15%) or more in the case of any person identified in
clause (iv) above) of the shares of Common Stock solely by reason of
purchases of Common Stock by the Company and shall, after such purchases by
the Company, become the Beneficial Owner of any additional shares of Common
Stock which has the effect of increasing such person's percentage ownership
of the then-outstanding shares of Common Stock by any means whatsoever,
then such person shall be deemed to have triggered a Change of Control; and
(b) if the Board of Directors determines that a person who would otherwise
be the Beneficial Owner of ten percent (10%) or more (fifteen percent (15%)
or more in the case of any person identified
A-7
in clause (iv) above) of the shares of Common Stock has become such
inadvertently (including, without limitation, because (1) such person was
unaware that it Beneficially Owned ten percent (10%) or more (fifteen
percent (15%) or more in the case of any person identified in clause (iv)
above) of the shares of Common Stock or (2) such person was aware of the
extent of such beneficial ownership but such person acquired beneficial
ownership of such shares of Common Stock without the intention to change or
influence the control of the Company) and such person divests itself as
promptly as practicable of a sufficient number of shares of Common Stock so
that such person would no longer be the Beneficial Owner of ten percent
(10%) or more (fifteen percent (15%) or more in the case of any person
identified in clause (iv) above), then such person shall not be deemed to
be, or have been, the Beneficial Owner of ten percent (10%) or more
(fifteen percent (15%) or more in the case of any person identified in
clause (iv) above) of the shares of Common Stock, and no Change of Control
shall be deemed to have occurred.
(B) During any period of two consecutive years, individuals who at the
beginning of such period constituted the Board of Directors and any new
director (other than a director initially elected or nominated as a
director as a result of an actual or threatened election contest with
respect to directors or any other actual or threatened solicitation of
proxies by or on behalf of such director) whose election by the Board of
Directors or nomination for election by the Company's shareholders was
approved by a vote of at least two-thirds (2/3) of the directors then still
in office who either were directors at the beginning of the period or whose
election or nomination for election was previously so approved, cease for
any reason to constitute a majority thereof.
(C) There shall be consummated any consolidation, merger or other
combination of the Company with any other person or entity other than:
(i) a consolidation, merger or other combination which would result
in the voting securities of the Company outstanding immediately prior
thereto continuing to represent (either by remaining outstanding or by
being converted into voting securities of the surviving entity) more
than fifty-one percent (51%) of the combined voting power of the voting
securities of the Company or such surviving entity outstanding
immediately after such consolidation, merger or other combination; or
(ii) a consolidation, merger or other combination effected to
implement a recapitalization and/or reorganization of the Company (or
similar transaction), or any other consolidation, merger or other
combination of the Company, which results in no person, together with
all Affiliates and Associates of such person, becoming the Beneficial
Owner of ten percent (10%) or more (fifteen percent (15%) or more in the
case of any person identified in clause (A)(iv) above) of the combined
voting power of the Company's then outstanding securities.
(D) There shall be consummated any sale, lease, assignment, exchange,
transfer or other disposition (in one transaction or a series of related
transactions) of fifty percent (50%) or more of the assets or earning power
of the Company (including, without limitation, any such sale, lease,
assignment, exchange, transfer or other disposition effected to implement a
recapitalization and/or reorganization of the Company (or similar
transaction)) which results in any person, together with all Affiliates and
Associates of such person, owning a proportionate share of such assets or
earning power greater than the proportionate share of the voting power of
the Company that such person, together with all Affiliates and Associates
of such person, owned immediately prior to any such sale, lease,
assignment, exchange, transfer or other disposition.
(E) The shareholders of the Company approve a plan of complete
liquidation of the Company.
A-8
For purposes of this Section 8.05, a person shall be deemed the "Beneficial
Owner" of and shall be deemed to "beneficially own" any securities:
(x) which such person or any of such person's Affiliates or Associates
is considered to be a "beneficial owner" under Rule 13d-3 of the General
Rules and Regulations under the Exchange Act, as in effect on April 23,
1997;
(y) which such person or any of such person's Affiliates or
Associates, directly or indirectly, has or shares the right to acquire,
hold, vote (except pursuant to a revocable proxy as described in the
proviso to this definition) or dispose of such securities (whether any such
right is exercisable immediately or only after the passage of time)
pursuant to any agreement, arrangement or understanding (whether or not in
writing), or upon the exercise of conversation rights, exchange rights,
rights, warrants or options, or otherwise; provided, however, that a person
shall not be deemed to be the Beneficial Owner of, or to beneficially own,
securities tendered pursuant to a tender or exchange offer made by or on
behalf of such person or any of such person's Affiliates or Associates
until such tendered securities are accepted for purchase or exchange; or
(z) which are beneficially owned, directly or indirectly, by any other
person (or any Affiliate or Associate of such other person) with which such
person (or any of such person's Affiliates or Associates) has any
agreement, arrangement or understanding (whether or not in writing), with
respect to acquiring, holding, voting (except as described in the proviso
to this definition) or disposing of any securities of the Company;
provided, however, that a person shall not be deemed the Beneficial Owner of,
nor to beneficially own, any security if such person has the right to vote such
security pursuant to an agreement, arrangement or understanding which (1) arises
solely from a revocable proxy given to such person in response to a public proxy
or consent solicitation made pursuant to, and in accordance with, the applicable
rules and regulations under the Exchange Act, and (2) is not also then
reportable on Schedule 13D (or any comparable or successor report) under the
Exchange Act; and provided, further, that nothing in this Section 8.05 shall
cause a person engaged in business as an underwriter or securities to be the
Beneficial Owner of, or to beneficially own, any securities acquired through
such person's participation in good faith in a firm commitment underwriting
until the expiration of forty (40) days after the date of such acquisition or
such later date as the Board of Directors may determine in any specific case.
8.06 Not an Employment Contract. The Plan shall not confer upon any
Eligible Employee or Participant any right with respect to continuance of
employment with the Company or any Subsidiary, nor shall it interfere in any way
with any right such Eligible Employee, Participant, the Company or any
Subsidiary would otherwise have to terminate such Eligible Employee's or
Participant's employment at any time.
8.07 Invalidity of Provisions. Should any part of the Plan for any reason
be declared by any court of competent jurisdiction to be invalid, such decision
shall not affect the validity of any remaining portion, which remaining portion
shall continue in full force and effect as if the Plan had been adopted with the
invalid portion hereof eliminated, it being the intention of the Company that it
would have adopted the remaining portion of the Plan without including any such
part, parts or portion which may for any reason be hereafter declared invalid.
8.08 Effective Date. The Plan will become effective on January 1, 2003
following its approval at a duly held meeting of the shareholders of the
Company. The Plan shall be deemed to have been adopted on the date of such
meeting.
A-9
ANNUAL MEETING OF SHAREHOLDERS
OF
THE SHERWIN-WILLIAMS COMPANY
Wednesday, April 24, 2002
9:00 A.M.
Landmark Conference Center
927 Midland Building
101 Prospect Avenue, N.W.
Cleveland, Ohio
AGENDA
------
- Fix the number of directors at eleven and elect eleven directors
to hold office until the next Annual Meeting of Shareholders and
until their successors are elected.
- Approve The Sherwin-Williams Company 2003 Stock Plan.
- Transact such other business as may properly come before the
Annual Meeting.
--------------------------------------------------------------------------------
YOUR VOTE IS IMPORTANT!
Whether or not you plan to attend the Annual Meeting, please promptly vote by
the Internet, by telephone, or by completing and returning the attached proxy
card. Voting early will help avoid additional solicitation costs and will not
prevent you from voting in person at the Annual Meeting if you wish to do so.
--------------------------------------------------------------------------------
[SHERWIN WILLIAMS LOGO]
THE SHERWIN-WILLIAMS COMPANY
PROXY/VOTING INSTRUCTION CARD
ANNUAL MEETING OF SHAREHOLDERS - APRIL 24, 2002
The undersigned authorizes C.M. CONNOR, J.M. SCAMINACE and L.E. STELLATO,
and each of them, with power of substitution, to vote and otherwise represent
all of the shares of common stock and convertible participating serial preferred
stock of The Sherwin-Williams Company which the undersigned is entitled to vote
at the Annual Meeting of Shareholders on April 24, 2002, and any adjournment(s)
thereof, as indicated on the reverse side, and in their discretion on all other
matters as may properly come before the Annual Meeting. This card also provides
voting instructions for shares of common stock, if any, held for the account of
the undersigned by The Bank of New York, as agent of the Stock Ownership and
Automatic Dividend Reinvestment Plan, and by Fidelity Management Trust Company,
as trustee of the Employee Stock Purchase and Savings Plan.
THIS CARD IS SOLICITED JOINTLY BY THE BOARD OF DIRECTORS, THE BANK OF NEW
YORK (WITH RESPECT TO SHARES HELD UNDER THE DIVIDEND REINVESTMENT PLAN) AND
FIDELITY (WITH RESPECT TO SHARES HELD UNDER THE STOCK PURCHASE AND SAVINGS
PLAN). YOU ARE ENCOURAGED TO SPECIFY YOUR VOTE BY COMPLETING THE REVERSE SIDE OF
THIS CARD. WHEN PROPERLY COMPLETED AND SIGNED, YOUR SHARES WILL BE VOTED IN
ACCORDANCE WITH YOUR DIRECTIONS. TO VOTE IN ACCORDANCE WITH THE BOARD OF
DIRECTORS' RECOMMENDATIONS, SIMPLY SIGN, DATE AND RETURN THIS CARD; NO BOXES
NEED BE MARKED. IF YOU SIGN, DATE AND RETURN THIS CARD WITHOUT SPECIFYING YOUR
VOTE, YOUR SHARES WILL BE VOTED FOR PROPOSALS 1 AND 2 AND IN THE PROXY HOLDER'S
DISCRETION UPON SUCH OTHER BUSINESS AS MAY PROPERLY COME BEFORE THE ANNUAL
MEETING. IF YOU DO NOT TIMELY RETURN THIS CARD, THE PROXY HOLDERS CAN NOT VOTE
YOUR SHARES (OR, IN THE CASE OF THE STOCK PURCHASE AND SAVINGS PLAN, IF YOU DO
NOT RETURN THIS CARD BY THE CLOSE OF BUSINESS ON APRIL 18, 2002, YOUR SHARES
WILL BE VOTED IN THE SAME PROPORTION AS FIDELITY VOTES THOSE SHARES FOR WHICH IT
RECEIVES PROPER INSTRUCTIONS).
(Continued and to be dated and signed on reverse side.)
THE SHERWIN-WILLIAMS COMPANY
P.O. BOX 11031
NEW YORK, N.Y. 10203-0031
[SHERWIN YOUR VOTE IS IMPORTANT!
WILLIAMS LOGO] VOTE BY INTERNET OR TELEPHONE
24 Hours a Day - 7 Days a Week
It's Fast and Convenient
INTERNET TELEPHONE MAIL
-------- --------- ----
1-888-216-1307
https://www.proxyvotenow.com/shw - Use any touch-tone telephone. - Mark, sign and date your proxy card
- Go to the website address listed above. - Have your proxy card ready. - Detach your proxy card.
- Have your proxy card ready. - Enter your Control Number located - Return your proxy card in the
- Enter your Control Number located in in the box below. postage-paid envelope provided.
the box below. - Follow the simple recorded
- Follow the simple instructions on the website. instructions.
Your Internet or telephone vote authorizes
the named proxies to vote your shares in the
same manner as if you marked, signed and
returned your proxy card. If you have
submitted your proxy by the Internet or
telephone there is no need for you to mail
back your proxy card.
1-888-216-1307
CALL TOLL-FREE TO VOTE
CONTROL NUMBER FOR
TELEPHONE OR INTERNET VOTING
THE INTERNET AND TELEPHONE VOTING FACILITIES WILL CLOSE AT 5:00 P.M. E.S.T. ON APRIL 23, 2002.
DETACH PROXY CARD HERE IF YOU ARE NOT VOTING BY THE INTERNET OR TELEPHONE
[ ] Sign, Date and Return this [X]
Card Promptly Using the
Enclosed Envelope. Votes must be indicated
(x) in Black or Blue ink.
A vote "FOR" this proposal is recommended by the Board of Directors.
1. ELECTION OF 11 DIRECTORS: 01-J.C. BOLAND,02-J.G. BREEN, 03-D.E. COLLINS, A vote "FOR" this proposal is recommended
04-C.M. CONNOR, 05-D.E. EVANS, 06-R.W. MAHONEY, 07-G.E. MCCULLOUGH, by the Board of Directors.
08-A.M. MIXON, III, 09-C.E. MOLL, 10-J.M. SCAMINACE, 11-R.K. SMUCKER
2. APPROVAL OF THE 2003 STOCK PLAN
FOR WITHHOLD
ALL FOR ALL EXCEPTIONS FOR AGAINST ABSTAIN
[ ] [ ] [ ] [ ] [ ] [ ]
(INSTRUCTIONS: To withhold authority to vote for any individual nominee, In their discretion, the proxy holders are
mark the "Exceptions" box and write that nominee's name on the line below). authorized to vote upon such other business
as may properly come before the Annual
Meeting or any adjournment thereof.
--------------------------------------------------------------------------
Mark this box if you have included a
change of address. [ ]
Mark this box if you have included [ ]
comments.
--------------------------------
SCAN LINE
--------------------------------
Please sign exactly as your name appears hereon.
Joint owners should each sign. When signing as
attorney, executor, administrator, trustee, guardian
or in other representative capacity, please give your
full title.
Date Shareholder sign here Co-Owner sign here
------------------------------------ -----------------------------